10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2015
OR
☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                 to                

Commission File No. 000-20354

LIGHTING SCIENCE GROUP CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	23-2596710
(State or other jurisdiction of incorporation)	(IRS Employer Identification No.)
1830 Penn Street, Melbourne, FL	32901
(Address of principal executive offices)	(Zip Code)

(321) 779-5520 

(Registrant’s telephone number, including area code)

Indicate by check mark whether registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  ☒   Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  ☒   Yes ☐   No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

☐ Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company

 Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  ☐  Yes ☒ No

The number of shares outstanding of the registrant’s Common Stock, par value $0.001 per share, as of August 7, 2015, was 211,886,165 shares.

LIGHTING SCIENCE GROUP CORPORATION
AND SUBSIDIARIES
FORM 10-Q
For the Quarter Ended June 30, 2015

Table of Contents

	Page
PART I
Item 1. Financial Statements	1
Condensed Consolidated Balance Sheets as of June 30, 2015 and December 31, 2014	1
Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three Months Ended June 30, 2015 and 2014	2
Condensed Consolidated Statements of Operations and Comprehensive Loss for the Six Months Ended June 30, 2015 and 2014	3
Condensed Consolidated Statement of Stockholders’ Deficit for the Six Months Ended June 30, 2015	4
Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2015 and 2014	5
Notes To The Condensed Consolidated Financial Statements (Unaudited)	6
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.	18
Item 4. Controls and Procedures	29
PART II
Item 1. Legal Proceedings	30
Item 6. Exhibits	30
SIGNATURES	30

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

LIGHTING SCIENCE GROUP CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

	June 30,			December 31,
	2015			2014
Assets
Current assets:
Cash and cash equivalents	$	346,572		$	1,609,297
Restricted cash		3,000,000			3,000,000
Accounts receivable, net		10,719,609			10,417,985
Inventories		20,046,254			22,726,162
Prepaid expenses		2,520,735			2,936,837
Other current assets		2,185,801			1,610,544
Total current assets		38,818,971			42,300,825
Property and equipment, net (includes accumulated depreciation of $11.3 million and $10.3 million as of June 30, 2015 and December 31, 2014, respectively)		1,733,073			2,650,115
Intangible assets, net		2,752,841			2,572,479
Pegasus Commitment		264,000			720,000
Debt issuance costs, less current portion		2,546,480			3,230,446
Other long-term assets		133,975			118,467
Total assets	$	46,249,340		$	51,592,332
Liabilities and Stockholders’ Deficit
Current liabilities:
Lines of credit	$	11,175,467		$	6,368,793
Current portion of long-term debt		69,061			58,574
Accounts payable		8,182,957			19,364,552
Provision for losses on non-cancelable purchase commitments		44,215			540,227
Accrued expenses		9,835,971			9,924,316
Total current liabilities		29,307,671			36,256,462
Note payable		28,516,029			27,813,061
Long-term debt, less current portion		-			35,272
Liabilities under derivative contracts		8,762,414			5,636,944
Total other liabilities		37,278,443			33,485,277
Total liabilities		66,586,114			69,741,739
Series H Redeemable Convertible Preferred Stock, $.001 par value, authorized 135,000 shares, 113,609 shares issued and outstanding as of June 30, 2015 and December 31, 2014, respectively		227,220,149			227,220,149
Series I Redeemable Convertible Preferred Stock, $.001 par value, authorized 90,000 shares, 62,365 shares issued and outstanding as of June 30, 2015 and December 31, 2014, respectively		124,736,627			124,736,627
Series J Redeemable Convertible Preferred Stock, $.001 par value, authorized 70,100 shares, 70,000 shares issued and outstanding as of June 30, 2015 and 58,475 shares issued and outstanding as of December 31, 2014		140,000,000			116,950,000
		491,956,776			468,906,776
Commitments and contingencies
Stockholders' deficit:
Preferred stock, $.001 par value, authorized 25,000,000 shares, 113,609 shares of Series H, 62,365 shares of Series I and 70,000 shares of Series J issued and outstanding as of June 30, 2015 and 113,609 shares of Series H, 62,365 shares of Series I and 58,475 shares of Series J issued and outstanding as of December 31, 2014
Common stock, $.001 par value, authorized 975,000,000 shares, 214,489,993 and 212,452,636 shares issued as of June 30, 2015 and December 31, 2014, respectively		214,490			212,453
Additional paid-in capital		310,865,676			320,175,440
Accumulated deficit		(816,373,976	)		(800,328,573	)
Accumulated other comprehensive loss		(3,242,240	)		(3,358,003	)
Treasury stock, 2,505,000 shares as of June 30, 2015 and December 31, 2014 , at cost		(3,757,500	)		(3,757,500	)
Total stockholders’ deficit		(512,293,550	)		(487,056,183	)
Total liabilities and stockholders’ deficit	$	46,249,340		$	51,592,332

The accompanying notes are an integral part of the condensed consolidated financial statements.

1

LIGHTING SCIENCE GROUP CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Unaudited)

	For the Three Months Ended June 30,
	2015			2014
Revenue	$	23,270,363		$	19,827,864
Cost of goods sold (exclusive of depreciation shown below)		19,853,828			18,826,446
Gross profit		3,416,535			1,001,418
Operating expense:
Selling, distribution and administrative (includes related party expenses of $0 and $261,000 for the three months ended June 30, 2015 and 2014, respectively)		6,896,060			9,981,850
Research and development		1,052,997			1,534,582
Restructuring expense		214,066			793
Depreciation and amortization		488,071			1,000,313
Total operating expenses		8,651,194			12,517,538
Loss from operations		(5,234,659	)		(11,516,120	)
Other income (expense):
Interest income		1,163			225
Interest expense		(1,590,638	)		(2,002,561	)
Related party interest expense		(138,300	)		(138,300	)
Decrease in fair value of liabilities under derivative contracts		4,595,279			1,983,150
Other (expense) income, net		(77,158	)		45,090
Total other income (expense)		2,790,346			(112,396	)
Net loss		(2,444,313	)		(11,628,516	)
Foreign currency translation gain (loss)		70,372			(21,899	)
Comprehensive loss	$	(2,373,941	)	$	(11,650,415	)
Basic and diluted net loss per weighted average common share attributable to controlling shareholders	$	(0.01	)	$	(0.04	)
Basic and diluted net loss per weighted average common share attributable to noncontrolling shareholders	$	(0.01	)	$	(0.04	)
Basic and diluted weighted average number of common shares outstanding attributable to controlling shareholders		298,344,752			234,753,151
Basic and diluted weighted average number of common shares outstanding attributable to noncontrolling shareholders		99,139,522			58,785,605

The accompanying notes are an integral part of the condensed consolidated financial statements.

2

LIGHTING SCIENCE GROUP CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Unaudited)

	For the Six Months Ended June 30,
	2015			2014
Revenue	$	42,641,908		$	45,753,705
Cost of goods sold (exclusive of depreciation shown below)		36,295,125			42,061,792
Gross profit		6,346,783			3,691,913
Operating expense:
Selling, distribution and administrative (includes related party expenses of $0 and $869,000 for the six months ended June 30, 2015 and 2014, respectively)		11,991,641			19,175,795
Research and development		2,234,310			3,078,606
Restructuring expense		297,770			205,845
Depreciation and amortization		994,143			2,076,323
Total operating expenses		15,517,864			24,536,569
Loss from operations		(9,171,081	)		(20,844,656	)
Other income (expense):
Interest income		1,163			636
Interest expense		(2,991,531	)		(3,284,319	)
Related party interest expense		(338,067	)		(199,767	)
Increase in fair value of liabilities under derivative contracts		(3,505,493	)		(27,496,388	)
Other (expense) income, net		(40,394	)		102,015
Total other expense		(6,874,322	)		(30,877,823	)
Net loss		(16,045,403	)		(51,722,479	)
Foreign currency translation gain		115,763			150,705
Comprehensive loss	$	(15,929,640	)	$	(51,571,774	)
Basic and diluted net loss per weighted average common share attributable to controlling shareholders	$	(0.08	)	$	(0.32	)
Basic and diluted net loss per weighted average common share attributable to noncontrolling shareholders	$	(0.08	)	$	(0.34	)
Basic and diluted weighted average number of common shares outstanding attributable to controlling shareholders		293,080,898			203,060,746
Basic and diluted weighted average number of common shares outstanding attributable to noncontrolling shareholders		98,407,895			47,908,501

The accompanying notes are an integral part of the condensed consolidated financial statements. 

3

LIGHTING SCIENCE GROUP CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIT

(Unaudited)

											Accumulated
					Additional						Other
	Common Stock				Paid-in			Accumulated			Comprehensive			Treasury
	Shares		Amount		Capital			Deficit			Loss			Stock			Total
Balance December 31, 2014		212,452,636	$	212,453	$	320,175,440		$	(800,328,573	)	$	(3,358,003	)	$	(3,757,500	)	$	(487,056,183	)
Issuance of restricted stock for directors' compensation		2,033,905		2,034		127,431			-			-			-			129,465
Stock based compensation expense		-		-		2,235,720			-			-			-			2,235,720
Stock issued under equity compensation plans		3,452		3		542			-			-			-			545
Issuance of Series J Warrants		-		-		3,638,443			-			-			-			3,638,443
Deemed dividends on Series J Redeemable Convertible Preferred Stock		-		-		(15,311,900	)		-			-			-			(15,311,900	)
Net loss		-		-		-			(16,045,403	)		-			-			(16,045,403	)
Foreign currency translation adjustment		-		-		-			-			115,763			-			115,763
Balance June 30, 2015		214,489,993	$	214,490	$	310,865,676		$	(816,373,976	)	$	(3,242,240	)	$	(3,757,500	)	$	(512,293,550	)

The accompanying notes are an integral part of the condensed consolidated financial statements.

4

LIGHTING SCIENCE GROUP CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	For the Six Months Ended June 30,
	2015			2014
Cash flows from operating activities:
Net loss	$	(16,045,403	)	$	(51,722,479	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		994,143			2,076,323
Issuance of restricted stock for directors' compensation		129,465			199,368
Stock based compensation expense		2,235,720			2,218,544
Non-cash sales incentive		75,977			61,521
Allowance for doubtful accounts receivable		35,725			25,758
Write-down of inventory		485,102			1,094,049
Provision for losses on non-cancelable purchase commitments		(496,012	)		(219,791	)
Increase in fair value of derivative contracts		3,505,493			27,496,388
Amortization of debt issuance costs		733,452			1,006,589
Medley discount accretion		389,536			279,167
Interest accrued on Medley Term Loan		313,432			224,308
(Gain) loss on disposal of assets		(500	)		50,199
Changes in operating assets and liabilities:
Accounts receivable		(313,140	)		1,199,862
Inventories		2,194,806			(6,100,128	)
Prepaid expenses		416,266			(739,662	)
Other current and long-term assets		(301,502	)		334,166
Accounts payable		(11,169,225	)		2,153
Accrued expenses and other liabilities		(70,796	)		(601,839	)
Net cash used in operating activities		(16,887,461	)		(23,115,504	)
Cash flows from investing activities:
Purchases of property and equipment		(36,806	)		(262,249	)
Capitalized patents		(220,652	)		(461,404	)
Proceeds from sale of property and equipment		500			375,100
Net cash used in investing activities		(256,958	)		(348,553	)
Cash flows from financing activities:
Net proceeds (payments) from draws on lines of credit and other short-term borrowings		4,806,674			(32,718,274	)
Proceeds from long-term borrowings		-			29,775,000
Payment of short and long-term debt		(24,785	)		(2,667	)
Debt issuance costs		(338,749	)		(3,210,206	)
Decrease in restricted cash related to line of credit		-			2,000,000
Proceeds from issuance of common stock under equity compensation plans		545			3,669
Proceeds from issuance of Series J Redeemable Convertible Preferred Securities		11,525,000			17,475,000
Fees incurred on issuance of preferred stock		(148,457	)		(485,400	)
Net cash provided by financing activities		15,820,228			12,837,122
Effect of exchange rate changes on cash		61,466			181,935
Net decrease in cash		(1,262,725	)		(10,445,000	)
Cash and cash equivalents balance at beginning of period		1,609,297			11,195,412
Cash and cash equivalents balance at end of period	$	346,572		$	750,412
Supplemental disclosures:
Interest paid during the period	$	2,597,495		$	2,562,656
Non-cash investing and financing activities:
Deemed dividends on Series J Redeemable Convertible Preferred Stock	$	(15,311,900	)	$	(30,332,379	)
Reclass of Series J Warrants from liabilities to equity	$	-		$	37,646,300
Reclass of THD Warrant from equity to liabilities	$	-		$	(74,576	)
Fair value of Pegasus Guaranty included in debt issuance costs	$	-		$	(2,766,000	)
Deemed dividends on issuance of Pegasus Guaranty Warrants	$	-		$	(570,574	)

The accompanying notes are an integral part of the condensed consolidated financial statements.

5

LIGHTING SCIENCE GROUP CORPORATION AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

NOTE 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

Overview

Lighting Science Group Corporation (the “Company”) was incorporated in Delaware in 1988 and designs, develops, manufactures and markets general illumination products that use light emitting diodes (“LEDs”) as their exclusive light source. The Company’s product portfolio includes LED-based retrofit lamps (replacement bulbs) used in existing light fixtures as well as purpose built LED-based luminaires (light fixtures). The Company’s lamps and luminaires are used for many common indoor and outdoor residential, commercial, industrial and public infrastructure lighting applications. The Company assembles and manufactures products primarily through its contract manufacturers in Asia.

Basis of Financial Statement Presentation

The accompanying unaudited condensed consolidated financial statements are presented pursuant to the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) in accordance with the disclosure requirements for the quarterly report on Form 10-Q and therefore do not include all of the information and footnotes required by generally accepted accounting principles in the United States of America (“GAAP”) for complete financial statements. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments) necessary to fairly state the results for the interim periods presented. The condensed consolidated balance sheet as of December 31, 2014 is derived from the Company’s audited financial statements. Operating results for the three and six months ended June 30, 2015 are not necessarily indicative of the results of the Company that may be expected for the year ending December 31, 2015. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements as of and for the year ended December 31, 2014 and notes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on March 31, 2015.

The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in the accompanying condensed consolidated financial statements.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expense during the reporting periods. The Company’s actual results could differ from these estimates.

Restricted Cash

As of June 30, 2015 and December 31, 2014, as required by the Company’s five-year term loan (as amended from time to time, the “Medley Term Loan”) with Medley Capital Corporation (“Medley”), the Company maintained a minimum restricted cash balance of $3.0 million to collateralize the Medley Term Loan. Changes in the restricted cash balance are reflected as a financing activity in the consolidated statement of cash flows.

Accounts Receivable

The Company records accounts receivable at the invoiced amount when its products are shipped to customers or when specific milestone billing requirements are completed. The Company’s accounts receivable balance is recorded net of allowances for amounts not expected to be collected from customers. This allowance for doubtful accounts is the Company’s best estimate of probable credit losses in the Company’s existing accounts receivable. Estimates used in determining the allowance for doubtful accounts are based on historical collection experience, age of receivables and known collectability issues. The Company writes off accounts receivable when it becomes apparent, based on age or customer circumstances, that such amounts will not be collected. The Company reviews its allowance for doubtful accounts on a quarterly basis. Recovery of bad debt amounts previously written off is recorded as a reduction of bad debt expense in the period the payment is collected. Generally, the Company does not require collateral for its accounts receivable and does not regularly charge interest on past due amounts. As of June 30, 2015 and December 31, 2014, the Company’s accounts receivable were reflected net of an allowance for doubtful accounts of $447,000 and $408,000, respectively.

6

As of June 30, 2015 and December 31, 2014, $5.2 million and $5.4 million, respectively, of eligible accounts receivable were pledged as collateral for the three-year asset based revolving credit facility (as amended from time to time, the “FCC ABL”) entered into on April 25, 2014 with FCC, LLC d/b/a First Capital (“First Capital”).

Revenue Recognition

The Company records revenue when its products are shipped and title passes to customers. When sales of products are subject to certain customer acceptance terms, revenue from such sales is recognized once those terms have been met. The Company also provides its customers with limited rights of return for non-conforming shipments or product warranty claims.

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (“ASU 2014‑09”). ASU 2014-09 seeks to clarify the principles for recognizing revenue and to develop a common revenue standard for GAAP and International Financial Reporting Standards. ASU 2014‑09 initially was effective for fiscal years, and interim periods within those years, beginning after December 15, 2016. However, at its July 9, 2015 meeting, the FASB agreed to defer by one year the mandatory effective date of this standard, but will also provide the option to adopt it as of the original effective date. The Company is currently evaluating the impact of adopting ASU 2014‑09, but the standard is not expected to have a significant effect on its consolidated financial statements.

Product Warranties

The Company generally provides a five-year limited warranty covering defective materials and workmanship of its products. Such warranty may require the Company to repair, replace or reimburse the purchaser for the purchase price of the product. The estimated costs related to warranties are accrued at the time products are sold based on various factors, including the Company’s stated warranty policies and practices, the historical frequency of claims and the cost to repair or replace its products under warranty. The warranty provision is included in accrued expenses on the condensed consolidated balance sheet. Changes in the warranty provision for the six months ended June 30, 2015 were as follows:

Warranty provision as of December 31, 2014	$	4,789,470
Additions to provision		925,361
Less warranty costs		(1,743,943	)
Warranty provision as of June 30, 2015	$	3,970,888

Fair Value Measurements

The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:

• Level 1 Inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.

• Level 2 Inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.

• Level 3 Inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.

Fair Value of Financial Instruments

Cash and cash equivalents, accounts receivable, accounts payable, amounts due under lines of credit and other short term borrowings, accrued expenses and the note payable are carried at amounts that approximate their fair value due to the short-term maturity of these instruments and/or variable, market driven interest rates.

7

The liabilities under derivative contracts, which represent warrants to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), were initially recorded at fair value and subsequently reflected at their fair value at the end of each reporting period. The fair value of the warrant issued to The Home Depot, Inc. (the “THD Warrant”) in January 2011, is determined using the Monte Carlo valuation method and will be adjusted at each reporting date until the underlying shares have been earned for each year. Such adjustments will be recorded as a reduction in the related revenue (sales incentive) from The Home Depot, Inc. ("The Home Depot"). Once a portion of the THD Warrant vests it is recorded at its fair value at the end of each subsequent reporting period.

Reclassification

Certain prior period amounts in the accompanying consolidated financial statements have been reclassified to conform to the current year presentation. These reclassifications had no effect on previously reported net loss or stockholders’ deficit.

NOTE 3. LIQUIDITY AND CAPITAL RESOURCES

As shown in the condensed consolidated financial statements, the Company has experienced significant net losses as well as negative cash flows from operations since its inception, resulting in an accumulated deficit of $816.4 million and stockholders’ deficit of $512.3 million as of June 30, 2015. As of June 30, 2015, the Company had cash and cash equivalents of $347,000 and an additional $3.0 million in restricted cash subject to a cash collateral dominion agreement pursuant to the Medley Term Loan. The Company’s cash expenditures primarily relate to procurement of inventory, payment of salaries, employee benefits and other operating costs.

The Company’s primary sources of liquidity have historically been borrowings from First Capital under the FCC ABL, from Medley under the Medley Term Loan and from other previous lenders, as well as sales of Common Stock and Preferred Stock (as defined below) to, and short-term loans from, affiliates of Pegasus Capital Advisors, L.P. (“Pegasus Capital”), including Pegasus Partners IV, L.P. (“Pegasus IV”), LSGC Holdings LLC (“LSGC Holdings”), LSGC Holdings II LLC (“Holdings II”), LSGC Holdings III LLC (“Holdings III”) and PCA LSG Holdings, LLC (“PCA Holdings” and collectively with Pegasus Capital, Pegasus IV, LSGC Holdings, Holdings II, Holdings III and their affiliates, “Pegasus”). Pegasus is the Company’s controlling stockholder.

The Company obtained the five-year, $30.5 million Medley Term Loan from Medley on February 19, 2014, pursuant to a Term Loan Agreement (as amended from time to time the “Medley Loan Agreement”). Pursuant to the Medley Loan Agreement, the Company is required to achieve a minimum quarterly fixed charge coverage ratio for the preceding 12-month period and to maintain certain minimum EBITDA levels. In connection with the Medley Term Loan, the Company issued a warrant to purchase 5,000,000 shares of Common Stock to each of Medley and Medley Opportunity Fund II LP (the “Medley Warrants”).

The Company also obtained a three-year revolving credit facility with a maximum line amount of $22.5 million from ACF Finco I LP (as assignee of First Capital) on April 25, 2014, pursuant to the terms of a Loan and Security Agreement (as amended from time to time, the “FCC ABL Agreement”). As of June 30, 2015, the Company had $11.2 million in borrowings outstanding under the FCC ABL Agreement and additional borrowing capacity of $2.0 million. The maximum borrowing capacity under the FCC ABL Agreement is based on a formula of eligible accounts receivable and inventory. The FCC ABL Agreement also requires the Company to achieve a minimum quarterly fixed charge coverage ratio for the preceding 12-month period.

On January 30, 2015, the Company issued 11,525 units of its Series J securities (“Series J Securities”), at a purchase price of $1,000 per Series J Security for aggregate proceeds of $11.5 million. Each Series J Security consists of (i) one share of Series J Preferred Stock and (ii) a warrant to purchase 2,650 shares of Common Stock, at an exercise price of $0.001 per share (the “Series J Warrants”). The Series J Securities were issued pursuant to a subscription agreement entered into between the Company and Holdings III.

Commencing on September 25, 2015, RW LSG Holdings LLC (“Riverwood”) and Pegasus will have the right to cause the Company to redeem their shares of Series H Convertible Preferred Stock (“Series H Preferred Stock”) and Series I Convertible Preferred Stock (“Series I Preferred Stock”), respectively. If either Riverwood or Pegasus elects to cause the Company to redeem its shares of Series H Preferred Stock or Series I Preferred Stock, all other holders of the applicable series will similarly have the right to request the redemption of their shares of Preferred Stock. In addition, commencing 10 business days after September 25, 2015, Portman Limited (“Portman”) and affiliates of Zouk Holdings Limited acting together, have a contractual right to require the Company to redeem their respective shares of Series H Preferred Stock. The Company is also required to redeem the outstanding shares of its Series J Convertible Preferred Stock (“Series J Preferred Stock” and collectively with Series H Preferred Stock and Series I Preferred Stock, the “Preferred Stock”) (a) subject to certain limited exceptions, immediately prior to the redemption of the Series H Preferred Stock, Series I Preferred Stock or any other security that ranks junior to the Series J Preferred Stock and (b) on November 14, 2019, at the election of the holders of Series J Preferred Stock (a “Special Redemption”). Holders of Preferred Stock would also have the right to require the Company to redeem such shares upon the uncured material breach of the Company’s obligations under its outstanding indebtedness or the uncured material breach of the terms of the certificates of designation governing the Preferred Stock. As of June 30, 2015, in the event the Company was required to redeem all of its outstanding shares of Preferred Stock, the Company’s maximum payment obligation would have been $492.0 million. The Company would be required to repay its outstanding obligations under the Medley Term Loan and the FCC ABL prior to any redemption of shares of Preferred Stock. As of June 30, 2015, the aggregate borrowings outstanding under these loan facilities was $39.7 million.

8

Any redemption of the Preferred Stock would be limited to funds legally available therefor under Delaware law. The certificates of designation governing the Preferred Stock provide that if there is not a sufficient amount of cash or surplus available to pay for a redemption of Preferred Stock, then the redemption must be paid out of the remaining assets of the Company. In addition, the certificates of designation governing Preferred Stock provide that the Company is not permitted or required to redeem any shares of Preferred Stock for so long as such redemption would result in an event of default under the Company’s credit facilities.

As of June 30, 2015, based solely on a review of the Company’s balance sheet, the Company did not have legally available funds under Delaware law to satisfy a redemption of its Preferred Stock. In addition, based solely on the Company’s projected balance sheet as of September 25, 2015, the Company does not believe that it will have legally available funds on or before September 25, 2015 to satisfy any such redemption.

The certificate of designation governing the Series H Preferred Stock also provides that upon the occurrence of a “control event,” the Company must take any and all actions required and permitted to fix the size of its board of directors to a size that would permit Riverwood (as the primary investor of the Series H Preferred Stock) to appoint a majority of the directors to the board until the Company satisfies or otherwise cures the obligations giving rise to the control event. A control event occurs if, among other things, Riverwood exercises its optional redemption right under the certificate of designation governing the Series H Preferred Stock and the Company is unable to redeem Riverwood’s Preferred Stock. If Riverwood were to exercise its optional redemption right and a control event were to occur, Riverwood could take control of the board of directors. In addition, if the Company does not have sufficient capital available to redeem the Series J Preferred Stock in connection with a Special Redemption of the Series J Preferred Stock, the Company will be required to issue a non-interest bearing note or notes (payable 180 days after issuance) in the principal amount of the liquidation amount of any shares of Series J Preferred Stock not redeemed by the Company in connection with such Special Redemption, subject to certain limitations imposed by Delaware law governing distributions to stockholders.

As discussed further in Note 14, one of the Company’s stockholders, Geveran Investments Limited (“Geveran”), filed a lawsuit against the Company and certain other defendants seeking, among other things, rescission of its $25.0 million investment in the Company. On August 28, 2014, the court presiding over the lawsuit granted Geveran’s motion for partial summary judgment with respect to its cause of action for violation of the Florida securities laws. As of June 30, 2015, the order relating to the judgment had not been entered. Although the Company cannot predict the ultimate outcome of this lawsuit, it believes the court’s summary judgment award in favor of Geveran is in error and that it has strong defenses against Geveran’s claims. In the event that the Company is not successful on appeal, it could be liable for Geveran’s $25.0 million investment, as well as interest, attorneys’ fees and court costs. After the order is entered, the Company plans to appeal and, together with the other defendants, post a bond, which would allow the Company to obtain an automatic stay of enforcement throughout the appeal process. The summary judgment order and the bond required to stay enforcement of the judgment could have an adverse effect on the Company’s liquidity and its ability to raise capital in the future.

The Company continues to face challenges in its efforts to achieve positive cash flows from operations and profitability. The Company’s ability to continue to meet its obligations in the ordinary course of business is dependent upon establishing profitable operations, which may be supplemented by any additional funds raised through public or private financing or increased borrowing capacity.

The Company’s supply agreement with The Home Depot, the term of which continues until July 23, 2016, does not require The Home Depot to purchase any minimum amount of products from the Company. Moreover, The Home Depot performs periodic product line reviews to assess its product offerings, which can lead to pricing pressures and/or a reallocation of its business to other suppliers. In June 2015, The Home Depot performed its most recent product line review which covered its entire private label LED lighting product offering. Although the Company has not been advised of the results of this product line review, such review could result in a material loss of revenue from sales to The Home Depot.

9

As a result of the Company’s historical and continuing losses, the Company believes it will likely need to raise additional capital to fund its operations. There can be no assurance that sources of additional capital will be available in an amount or on terms that are acceptable to the Company, if at all. If the Company is not able to raise such additional capital, the Company may need to restructure or refinance its existing obligations, which restructuring or refinancing would require the consent and cooperation of the Company’s creditors and certain stockholders. In such event, there can be no assurance that such restructuring or refinancing could be accomplished on terms that are acceptable to the Company, if at all.

NOTE 4. DETAIL OF CERTAIN BALANCE SHEET ACCOUNTS

Inventories

Inventories consisted primarily of finished goods as of June 30, 2015 and December 31, 2014. As of June 30, 2015 and December 31, 2014, inventories were stated net of inventory write downs of $5.1 million and $7.9 million, respectively. The Company considered a number of factors in estimating the required inventory write downs, including (i) the focus of the business on the next generation of the Company’s products, which utilize lower cost technologies, (ii) the strategic focus on core products to meet the demands of key customers and (iii) the expected demand for the Company’s current generation of products, which is approaching the end of its lifecycle upon the introduction of the next generation of products.

Property and Equipment, Net

Depreciation related to property and equipment was $467,000 and $985,000 for the three months ended June 30, 2015 and 2014, respectively. Depreciation related to property and equipment was $954,000 and $2.1 million for the six months ended June 30, 2015 and 2014, respectively.

NOTE 5. INTANGIBLE ASSETS

Intangible assets that have finite lives are amortized over their useful lives. The Company’s intangible assets as of June 30, 2015 and December 31, 2014 are detailed below:

	Cost, Less Impairment Charges		Accumulated Amortization			Net Book Value		Estimated Remaining Useful Life (years)
June 30, 2015:
Technology and intellectual property	$	3,017,232	$	(264,391	)	$	2,752,841	2.2 to 20.0
December 31, 2014:
Technology and intellectual property	$	2,796,580	$	(224,101	)	$	2,572,479	2.7 to 20.0

Total intangible asset amortization expense was $21,000 and $16,000 for the three months ended June 30, 2015 and 2014, respectively. Total intangible asset amortization expense was $40,000 and $29,000 for the six months ended June 30, 2015 and 2014, respectively.

NOTE 6. DEBT ISSUANCE COSTS

The Company capitalizes its costs related to the issuance of long-term debt and amortizes these costs using the effective interest rate method over the life of the loan. Amortization of debt issuance costs and the accelerated write-off of debt issuance costs in connection with refinancing activities are recorded as a component of interest expense. As of June 30, 2015, the current portion of the debt issuance costs was $1.6 million and was included in other current assets. In connection with the FCC ABL and the Medley Term Loan, $6.0 million of debt issuance costs were capitalized, including $2.8 million related to the fair value of the guaranty of the Company’s obligations under the Medley Loan Agreement in favor of Medley (the “Pegasus Guaranty”) provided by Pegasus Capital Partners IV, L.P. and Pegasus Capital Partners V, L.P. (collectively, the “Pegasus Guarantors”). The Company amortized $400,000 and $819,000 of debt issuance costs for the three months ended June 30, 2015 and 2014, respectively. The Company amortized $733,000 and $1.0 million of debt issuance costs for the six months ended June 30, 2015 and 2014, respectively.

NOTE 7. LINES OF CREDIT AND NOTE PAYABLE

	Balance Outstanding as of
Facility	June 30, 2015		December 31, 2014
FCC ABL, revolving line of credit	$	11,175,467	$	6,368,793
Medley Term Loan		28,516,029		27,813,061
	$	39,691,496	$	34,181,854

10

FCC ABL

On April 25, 2014, the Company, entered into the FCC ABL, which provides the Company with a maximum borrowing capacity of $22.5 million, which capacity is based on a formula of eligible accounts receivable and inventory. As of June 30, 2015, the Company had additional borrowing capacity of $2.0 million. As of June 30 2015, eligible collateral included $5.2 million of accounts receivable and $8.5 million of inventory. Borrowings under the FCC ABL bear interest at a floating rate equal to one-month LIBOR plus 4.0% per annum. As of June 30, 2015, the interest rate on the FCC ABL was 4.18%.

On January 30, 2015, the Company entered into an amendment to the FCC ABL, which provided additional notification and consent requirements as well as updates to certain disclosure schedules to the FCC ABL agreement. In connection with this amendment First Capital also agreed to amend the calculation of EBITDA for purposes of determining compliance with the fixed charge coverage ratio covenant for each of the six-month period ending March 31, 2015, the nine-month period ending June 30, 2015, the twelve-month period ending September 30, 2015 and the twelve-month period ending December 31, 2015.

Medley Term Loan

On February 19, 2014, the Company entered into the Medley Term Loan, which provided the Company with a $30.5 million term loan facility. The Medley Term Loan bears interest at a floating rate equal to three-month LIBOR plus 12% per annum, and as of June 30, 2015, the interest rate on the Medley Term Loan was 12.28%. Additionally, $3.0 million of the Medley Term Loan was funded directly into a deposit account to which Medley has exclusive access, to further secure the loan. The outstanding principal balance and all accrued and unpaid interest on the Medley Term Loan are due and payable on February 19, 2019. The Company recognized $195,000 of interest expense for the accretion of the discounts to the balance of the Medley Term Loan related to commitment fees and the Medley Warrants for both the three months ended June 30, 2015 and 2014, and $158,000 and $155,000 of accrued interest for the three months ended June 30, 2015 and 2014, respectively. The Company recognized $390,000 of interest expense for the accretion of the discounts to the balance of the Medley Term Loan related to commitment fees and the Medley Warrants and $313,000 of accrued interest for the six months ended June 30, 2015, and $279,000 of interest expense for the accretion of the discounts to the balance of the Medley Term Loan related to the commitment fees and the Medley Warrants and $224,000 of accrued interest for the period from February 19, 2014 (date of issuance) to June 30, 2014.

On January 30, 2015, the Company entered into an amendment to the Medley Term Loan, which, among other things, provided additional notification and consent requirements, amends the minimum EBITDA covenant levels with respect to each of the six-month period ending March 31, 2015, the nine-month period ending June 30, 2015, the twelve-month period ending September 30, 2015 and the twelve-month period ending December 31, 2015 and amended the definition of fixed charge coverage ratio.

11

NOTE 8. FAIR VALUE MEASUREMENTS

The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of June 30, 2015, according to the valuation techniques the Company used to determine their fair values:

	Fair Value Measurement as of June 30, 2015
	Quoted Price in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
	Level 1		Level 2		Level 3
Assets (Recurring):
Pegasus Commitment	$	-	$	-	$	264,000
Liabilities (Recurring):
Riverwood Warrants	$	-	$	-	$	3,357,970
September 2012 Warrants		-		-		264,000
Pegasus Warrant		-		-		1,856,000
THD Warrant		-		-		207,617
Medley Warrants		-		-		1,489,186
Pegasus Guaranty Warrants		-		-		1,587,641
	$	-	$	-	$	8,762,414

The following table is a reconciliation of the beginning and ending balances for assets and liabilities that were accounted for at fair value on a recurring basis using Level 3 inputs, as defined above, for the six months ended June 30, 2015:

				Realized and unrealized			Purchases, sales,		Transfers in
	Balance			gains (losses) included			issuances and		or out of		Balance
	December 31, 2014			in net loss			settlements		Level 3		June 30, 2015
Pegasus Commitment	$	720,000		$	(456,000	)	$	-	$	-	$	264,000
Riverwood Warrants		(2,352,027	)		(1,005,943	)		-		-		(3,357,970	)
September 2012 Warrants		(720,000	)		456,000			-		-		(264,000	)
Pegasus Warrant		(1,300,000	)		(556,000	)		-		-		(1,856,000	)
THD Warrant		(43,928	)		(163,689	)		-		-		(207,617	)
Medley Warrants		(577,065	)		(912,121	)		-		-		(1,489,186	)
Pegasus Guaranty Warrants		(643,924	)		(943,717	)		-		-		(1,587,641	)
Total	$	(4,916,944	)	$	(3,581,470	)	$	-	$	-	$	(8,498,414	)

The following table is a reconciliation of the beginning and ending balances for assets and liabilities that were accounted for at fair value on a recurring basis using Level 3 inputs, as defined above, for the six months ended June 30, 2014:

				Realized and unrealized			Purchases, sales,			Transfers in
	Balance			gains (losses) included			issuances and			or out of			Balance
	December 31, 2013			in net loss			settlements			Level 3			June 30, 2014
Pegasus Commitment	$	1,407,335		$	592,665		$	-		$	-		$	2,000,000
Riverwood Warrants		(5,002,664	)		(1,691,565	)		-			-			(6,694,229	)
September 2012 Warrants		(1,407,335	)		(592,665	)		-			-			(2,000,000	)
Pegasus Warrant		(2,765,047	)		(934,953	)		-			-			(3,700,000	)
THD Warrant		-			-			-			(74,576	)		(74,576	)
Series J Warrants		-			(25,140,561	)		(12,505,739	)		37,646,300			-
Medley Warrants		-			139,858			(3,170,361	)		-			(3,030,503	)
Pegasus Guaranty Warrants		-			130,833			(3,336,574	)		-			(3,205,741	)
Total	$	(7,767,711	)	$	(27,496,388	)	$	(19,012,674	)	$	37,571,724		$	(16,705,049	)

NOTE 9. STOCKHOLDERS' EQUITY

For the three months ended June 30, 2015 and 2014, the Company recorded expense of $118,000 and $126,000, respectively, related to restricted stock awards to the Company’s directors. For the six months ended June 30, 2015 and 2014, the Company recorded expense of $129,000 and $199,000, respectively, related to restricted stock awards to the Company’s directors.

On June 12, 2014, the Board approved the formation of a Scientific Advisory Board (the “SAB”) and issued restricted stock awards to each of the five members of the SAB as part of their compensation package. For the three and six months ended June 30, 2015, the Company recorded expense of $30,000 and $63,000, respectively, related to restricted stock awards to the Company’s SAB.

12

Warrants for the Purchase of Common Stock

As of June 30, 2015, the following warrants for the purchase of Common Stock were outstanding:

Warrant Holder	Reason for Issuance	Number of Common Shares		Exercise Price		Expiration Date
Investors in rights offering	Series D Warrants		1,072,617	$	2.95 to $2.96	March 3, 2022 through April 19, 2022
The Home Depot	Purchasing agreement		7,609,183	$	1.05	December 31, 2015 through 2018
RW LSG Management Holdings LLC	Riverwood Warrants		12,664,760	Variable		May 25, 2022
Certain other investors	Riverwood Warrants		5,427,751	Variable		May 25, 2022
Cleantech Europe II (A) LP	September 2012 Warrants		3,406,041	$	0.72	September 25, 2022
Cleantech Europe II (B) LP	September 2012 Warrants		593,959	$	0.72	September 25, 2022
Portman Limited	September 2012 Warrants		4,000,000	$	0.72	September 25, 2022
Aquillian Investments LLC	Private Placement Series H		830,508	$	1.18	September 25, 2017
Pegasus	Pegasus Warrant		10,000,000	Variable		May 25, 2022
Investors in Series J Follow-On Offering	Series J Warrants		185,500,000	$	0.001	January 3, 2019 through January 30, 2020
Medley	Medley Warrants		10,000,000	$	0.95	February 19, 2024
Pegasus	Pegasus Guaranty Warrants		10,000,000	$	0.50	February 19, 2024
			251,104,819

NOTE 10: EARNINGS (LOSS) PER SHARE

In 2012, the Company determined that two classes of Common Stock had been established for financial reporting purposes only, with Common Stock attributable to controlling stockholders representing shares beneficially owned and controlled by Pegasus and the Common Stock attributable to noncontrolling stockholders representing the minority interest stockholders. For the three and six months ended June 30, 2015 and 2014, the Company computed net loss per share of noncontrolling stockholders and controlling stockholders of Common Stock using the two-class method. Net loss from operations is initially allocated based on the underlying common shares held by controlling and noncontrolling stockholders. The allocation of the net losses attributable to the Common Stock attributable to controlling stockholders is then reduced by the amount of the deemed dividend related to the warrants issued to the Pegasus Guarantors, while the allocation of net losses attributable to the Common Stock attributable to noncontrolling stockholders is increased by the amount of the deemed dividend related to the warrants issued to the Pegasus Guarantors

13

The following table sets forth the computation of basic and diluted net loss per share of Common Stock:

	For the Three Months Ended June 30,
	2015						2014
	Controlling Stockholders			Noncontrolling Stockholders			Controlling Stockholders			Noncontrolling Stockholders
Basic and diluted net income per share:
Net loss attributable to common stock	$	(1,834,659	)	$	(609,654	)	$	(9,299,729	)	$	(2,328,787	)
Deemed dividends related to the Series J Preferred Stock attributable to all shareholders		(10,238	)		(3,402	)		(106,973	)		(26,787	)
Undistributed net loss	$	(1,844,897	)	$	(613,056	)	$	(9,406,702	)	$	(2,355,574	)
Basic and diluted weighted average number of common shares outstanding		298,344,752			99,139,522			234,753,151			58,785,605
Basic and diluted net loss per common share	$	(0.01	)	$	(0.01	)	$	(0.04	)	$	(0.04	)

	For the Six Months Ended June 30,
	2015						2014
	Controlling Stockholders			Noncontrolling Stockholders			Controlling Stockholders			Noncontrolling Stockholders
Basic and diluted net income per share:
Net loss attributable to common stock	$	(12,012,096	)	$	(4,033,307	)	$	(41,848,973	)	$	(9,873,506	)
Deemed dividends due to the issuance of Pegasus Guaranty Warrantsas compensation for guaranty provided by controlling shareholders		-			-			570,574			(570,574	)
Deemed dividends related to the Series J Preferred Stock attributable to all shareholders		(11,462,973	)		(3,848,927	)		(24,542,113	)		(5,790,266	)
Undistributed net loss	$	(23,475,069	)	$	(7,882,234	)	$	(65,820,512	)	$	(16,234,346	)
Basic and diluted weighted average number of common shares outstanding		293,080,898			98,407,895			203,060,746			47,908,501
Basic and diluted net loss per common share	$	(0.08	)	$	(0.08	)	$	(0.32	)	$	(0.34	)

Basic earnings per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding for the applicable period. The Series J Warrants have an exercise price of $0.001 per share of Common Stock, and are included in the weighted average number of shares of Common Stock outstanding as there are no conditions that must be satisfied before such warrant may be exercised into the shares of Common Stock underlying such warrants. Diluted earnings per share is computed in the same manner as basic earnings per share except the number of shares is increased to assume exercise of potentially dilutive stock options, unvested restricted stock and contingently issuable shares using the treasury stock method and convertible preferred shares using the if-converted method, unless the effect of such increases would be anti-dilutive. The Company had 265.9 million and 188.7 million common stock equivalents for the three months ended June 30, 2015 and 2014, respectively, and 260.2 million and 191.0 million common stock equivalents for the six months ended June 30, 2015 and 2014, respectively, which were not included in the diluted net loss per common share as the common stock equivalents were anti-dilutive, as a result of being in a net loss position.

NOTE 11: RELATED PARTY TRANSACTIONS 

Pegasus Capital is an affiliate of Pegasus IV and LSGC Holdings, which are the Company’s largest stockholders and beneficially owned approximately 88.6% of the Common Stock as of June 30, 2015.

On January 30, 2015, the Company issued an additional 11,525 units of Series J Securities, at a purchase price of $1,000 per Series J Security for aggregate proceeds of $11.5 million. The Series J Securities were issued pursuant to a subscription agreement between the Company and Holdings III, an affiliate of Pegasus Capital.

14

NOTE 12. RESTRUCTURING EXPENSE

The following table summarizes the Company’s restructuring expense and related charges for the periods indicated:

	For the Six Months Ended June 30,
	2015		2014
Broad based reduction of facilities and personnel (1)	$	297,770	$	91,568
Organization Optimization Initiative (2)		-		114,277
Total	$	297,770	$	205,845

(1) These charges relate to a significant cost reduction plan initiated during the fourth quarter of 2013 that includes moving the majority of the Company’s manufacturing to its contract manufacturers in Asia, related workforce reductions in Satellite Beach, Florida and cost reductions in our foreign subsidiaries. The Company estimates it will incur $200,000 in additional expenses throughout this cost reduction plan, primarily related to additional headcount reductions. These additional costs are expected to be incurred during 2015.

(2) In September 2011, the Company began implementing a restructuring plan designed to further increase efficiencies across the organization and lower the overall cost structure. In 2012, the Company extended the restructuring plan to further increase efficiencies across the organization and lower its overall cost structure. The plan included a significant reduction in full time headcount and the closing of the Company’s offices in the United Kingdom and Australia. For the six months ended June 30, 2014, these expenses related to the final liquidation of the Australian entity.

As of June 30, 2015, the accrued liability associated with the restructuring and other related charges consisted of the following:

	Workforce			Excess			Other
	Reduction			Facilities			Exit Costs			Total
Accrued liability as of December 31, 2014	$	959,240		$	353,269		$	138,840		$	1,451,349
Charges		297,770			-			-			297,770
Payments		(801,012	)		(77,207	)		(1,013	)		(879,232	)
Accrued liability as of June 30, 2015	$	455,998		$	276,062		$	137,827		$	869,887

The remaining accrual of $870,000 as of June 30, 2015 is expected to be paid during the year ending December 31, 2015.

The restructuring and other related charges are included in the line item restructuring expense in the condensed consolidated statement of operations and comprehensive loss.

NOTE 13. CONCENTRATIONS OF CREDIT RISK 

For the three months ended June 30, 2015 and 2014, revenue derived from sales to The Home Depot represented 93% and 72%, respectively, of the Company’s total revenue. For the six months ended June 30, 2015 and 2014, revenue derived from sales to The Home Depot represented 87% and 75%, respectively, of total revenue.

As of June 30, 2015 and December 31, 2014, The Home Depot accounts receivable balance represented 79% and 66%, respectively, of the Company’s total accounts receivable, net of allowances.

NOTE 14. COMMITMENTS AND CONTINGENCIES 

The Company is subject to the possibility of loss contingencies arising in its business. Such contingencies are accounted for in accordance with ASC Topic 450, “Contingencies.” In determining loss contingencies, the Company considers the possibility of a loss and the ability to reasonably estimate the amount of such loss or liability. An estimated loss is recorded when it is considered probable that a liability has been incurred and when the amount of loss can be reasonably estimated.

15

Legal Proceedings

In the ordinary course of business, the Company is routinely a party to various pending and threatened legal claims and proceedings. While the ultimate outcome of these matters cannot be predicted with certainty, based on information currently available and advice of counsel, and taking into account available insurance coverage, except as noted below, the Company does not believe that the outcome of any of these claims will have a material adverse effect on its business, financial condition or results of operations. However, the results of legal proceedings cannot be predicted with certainty, and in the event of unexpected future developments the ultimate resolution of one or more of these matters could be unfavorable. Should the Company fail to prevail in any of these legal matters or should several of these legal matters be resolved against the Company in the same reporting period, the consolidated financial position or operating results could be materially adversely affected. Regardless of the outcome, any litigation may require the Company to incur significant expenses and may result in significant diversion of management’s attention. Further, during its ordinary course of business, the Company enters into obligations to defend, indemnify and/or hold harmless various customers, officers, directors, employees, and other third parties. These contractual obligations could give rise to additional litigation costs and involvement in court proceedings.

Geveran Investments Limited v. Lighting Science Group Corporation, et al. (the “Geveran Case”)

On June 22, 2012, Geveran Investments Limited (“Geveran”), one of the Company’s stockholders, filed a lawsuit against the Company and several other defendants in the Circuit Court of the Seventeenth Judicial Circuit in and for Broward County, Florida. On October 30, 2012, the court entered an order transferring the lawsuit to the Ninth Judicial Circuit in and for Orange County, Florida. The Geveran Case names the Company as a defendant, as well as Pegasus Capital and nine other entities affiliated with Pegasus Capital; Richard Weinberg, our former Director and former interim Chief Executive Officer and a former partner of Pegasus Capital; Gregory Kaiser, a former Chief Financial Officer; J.P. Morgan Securities, LLC (“J.P. Morgan”); and two employees of J.P. Morgan. Geveran seeks rescission of its $25.0 million investment in the Company, as well as recovery of interest, attorneys’ fees and court costs, jointly and severally against the Company, Pegasus Capital, Mr. Weinberg, Mr. Kaiser, J.P. Morgan and the two J.P. Morgan employees, for alleged violations of Florida securities laws. Geveran alternatively seeks unspecified money damages, as well as recovery of court costs, for alleged common law negligent misrepresentation against these same defendants. In August 2014, the court granted Geveran’s motion to amend their first amended complaint to assert a claim for punitive damages against the defendants.

On August 28, 2014, the court issued an Order Granting Plaintiff’s Motion for Partial Summary Judgment under its First Cause of Action for Violation of the Florida Securities and Investor Protection Act (the “August 28 Order”). It is anticipated that the August 28 Order will be entered as a judgment of Court in August or September 2015. Once the August 28 Order is entered, the Company intends to appeal it. Together with the other defendants, the Company will have 30 days to post a bond during which time enforcement of the judgment would be stayed. The Company plans to have a bond posted to secure the judgment, which should result in the automatic stay of enforcement through the appeal process.

While the outcome of any appeal is inherently difficult to predict, the Company believes that the trial court’s grant of summary judgment to plaintiff was in error. In the event that the summary judgment is overturned on appeal, the Company believes it has strong defenses against Geveran’s claims. The Company denies liability in connection with this matter and intends to continue to vigorously defend itself against the claims asserted by Geveran. Nonetheless, the amount of possible loss, if any, cannot be reasonably estimated at this time. The outcome, if unfavorable, would have a material adverse effect on the Company’s financial position. The Company believes that, subject to the terms and conditions of the relevant policies (including retention and policy limits), directors’ and officers’ insurance coverage will be available to cover the substantial majority of its legal fees and costs in this matter. However, given the unspecified nature of Geveran’s maximum damage claims, insurance coverage may not be available for, or such coverage may not be sufficient to fully pay, a judgment or settlement in favor of Geveran. Based upon the terms of an indemnification agreement described below, the Company has also paid, and is likely to pay in the in the future, reasonable legal expenses incurred by J.P. Morgan and its affiliates in this lawsuit in connection with the engagement of J.P. Morgan as placement agent for the private placement with Geveran. Such payments are not covered by the Company’s insurance policies. The engagement letter executed with J.P. Morgan provides that the Company will indemnify J.P. Morgan and its affiliates from liabilities relating to J.P. Morgan’s activities as placement agent, unless such activities are finally judicially determined to have resulted from J.P. Morgan’s bad faith, gross negligence or willful misconduct.

16

GE Lighting Solutions v. Lighting Science Group Corporation, et al.

The Company is also a defendant in an action brought by GE Lighting Solutions LLC (“GE Lighting”) in Federal District Court for the Northern District of Ohio in or about January 2013. GE Lighting asserts a claim of infringement by the Company, as well as five other LED manufacturers, of U.S Patent No. 6,787,999, entitled LED-Based Modular Lamp, and U.S. Patent No. 6,799,864, entitled High Power LED Power Pack for Spot Module Illumination, and seeks monetary damages and an injunction. The Company denies liability in connection with this matter, asserts non-infringement defenses, and also asserts that the patents include terms that are indefinite and thus are invalid. On August 5, 2015, the Federal District Court granted the Company’s summary judgment motion invalidating the two GE patents at issue for indefiniteness, and dismissing GE’s patent infringement claims against the Company and the other defendants.  GE will have 30 days from the date the judgment is entered in which to file a notice of appeal.  If such an appeal were filed, the appellate court could reverse the judgment and remand the case back to the Federal District Court for further proceedings.

Other

In addition, the Company may be a party to a variety of legal actions, such as employment and employment discrimination-related suits, employee benefit claims, breach of contract actions, tort claims, shareholder suits, including securities fraud, intellectual property related litigation, and a variety of legal actions relating to its business operations. In some cases, substantial punitive damages may be sought. The Company currently has insurance coverage for certain of these potential liabilities. Other potential liabilities may not be covered by insurance, insurers may dispute coverage or the amount of insurance may not be sufficient to cover the damages awarded. In addition, certain types of damages, such as punitive damages, may not be covered by insurance and insurance coverage for all or certain forms of liability may become unavailable or prohibitively expensive in the future.

17

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This section and other parts of this Quarterly Report on Form 10-Q (this “Form 10-Q”) contain forward-looking statements that involve risks and uncertainties. Forward-looking statements can be identified by words such as “expects,” “anticipates,” “could,” “intends,” “seeks,” “estimates,” “believes,” “plans,” “predicts,” and similar terms. Forward-looking statements are not guarantees of future performance and our actual results may differ significantly from the results discussed in the forward-looking statements. Factors that might cause such differences include, but are not limited to, those discussed in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2014 filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 31, 2015 (the “Form 10-K”) and the Condensed Consolidated Financial Statements and notes thereto included elsewhere in this Form 10-Q. Our results of operations in any past period should not be considered indicative of the results to be expected for future periods. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this Form 10-Q. The forward-looking statements in this document are intended to be subject to the safe harbor protection provided by Sections 27A of the Securities Act of 1933, as amended (the “Securities Act”) and 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We assume no obligation to revise or update any forward-looking statements for any reason, except as required by law.

Company Overview

We are an innovator and provider of light emitting diode (“LED”) lighting technology. We design, develop, manufacture and market advanced illumination products that use LEDs as their exclusive light source. Our product portfolio includes LED-based retrofit lamps (replacement bulbs) used in existing light fixtures as well as purpose-built LED-based luminaires (light fixtures). Our lamps and luminaires are used for many common indoor and outdoor residential, commercial, industrial and public infrastructure lighting applications. We have also developed LED lighting technology whose light and color are tuned to achieve specific biological effects. We believe our proprietary technology, unique designs and key relationships throughout the LED lighting supply chain position us favorably to capitalize on the expanding acceptance of LEDs as a lighting source.

Our strategic plan consists of creating strong digital lighting brands in the consumer, residential, commercial and industrial markets. We believe that developing innovative and differentiated brands will deliver strong financial returns and a more loyal user base that is less price sensitive. We intend to continue to implement a nimble and agile “go-to-market” business model and manufacturing and product development system to streamline the processes used to introduce new products. We also intend to continue focusing on developing breakthrough innovation and on becoming a market maker in targeted value-added, high-margin segments within the lighting market. Finally, we plan to reduce our cost structure, preserve cash flow and strengthen liquidity to enhance our financial position.

We have also focused on expanding and optimizing our global supply chain to meet forecasted demand for our products while addressing the inefficiencies that have compressed our gross margin and overall financial performance in prior periods such as costs incurred to expedite the production or delivery of component parts. We anticipate long-term gross margin improvement as we continue to execute on our initiatives. We completed one of our most critical initiatives in 2014 with the transition of the manufacturing of our high volume lamps from Mexico and Satellite Beach, Florida to our contract manufacturing partners in Asia, from which we source the majority of our components. We began this transition in the third quarter of 2013, and completed it during the first half of 2014. We anticipate these actions will result in improved gross margin, as well as a more optimized product supply in future periods.

We continue to focus on increasing our brand awareness and improving our product promotion through prominent displays at our retailers and by conducting high visibility national media promotions with our key customers. Specifically, we continue to work with major media outlets, grant interviews and work with key consumer influencers to gain greater visibility for our brand and our scientifically proven technology. In 2013 we were featured in Men’s Health magazine,Condé Nast Traveler, National Geographic, Popular Science, Wall Street Journal online and ABC newswire. During 2014 we were featured on the Dr. OZ Show, The Rachael Ray Show, Live! With Kelly and Michael, Architectural SSL and other prominent national and local news affiliates.  Additionally, in 2014, we were ranked in the Top 500 of Deloitte’s 2014 Technology Fast 500™ in North America for the third consecutive year.

18

Financial Results

The following table sets forth our revenue, cost of goods sold and gross profit for the three and six months ended June 30, 2015 and 2014:

	Three Months Ended June 30,						Six Months Ended June 30,
	2015			2014			2015			2014
Revenue	$	23,270,363		$	19,827,864		$	42,641,908		$	45,753,705
Cost of goods sold		19,853,828			18,826,446			36,295,125			42,061,792
Gross profit (loss)	$	3,416,535		$	1,001,418		$	6,346,783		$	3,691,913
GAAP gross profit (loss) percentage		14.7	%		5.1	%		14.9	%		8.1	%

Our revenue is primarily derived from sales of our LED-based retrofit lamps and luminaires. Our revenue increased $3.4 million during the three months ended June 30, 2015, as compared to the three months ended June 30, 2014. This increase in revenue primarily resulted from a $7.4 million increase in sales to The Home Depot, Inc. (“The Home Depot”), which was offset by a $4.0 million decrease in sales to other customers. The increase in sales to The Home Depot during the three months ended June 30, 2015 was partially driven by our delivery of products during the period that were originally scheduled for delivery during the three months ended March 31, 2015, but were delayed due to port disruptions and harsh winter weather. Our revenue decreased $3.1 million during the six months ended June 30, 2015, as compared to the six months ended June 30, 2014. This decrease in revenue primarily resulted from a $6.0 million decrease in sales to customers other than The Home Depot, which was partially offset by a $2.9 million increase in sales to The Home Depot. During the six months ended June 30, 2015, our gross margin improvement was primarily attributed to our transition to lower cost contract manufacturers in Asia, which was substantially complete as of June 30, 2014.

We continue to pursue new relationships with retailers and original equipment manufacturers (“OEMs”) to help increase our sales. In addition, we have significantly increased the roster of distributors and independent sales agents that sell our products and added experienced professionals to our direct sales force to increase the frequency and impact of our activities with key national accounts that are targets for potential adoption of LED lighting.

Our gross margins are principally driven by the mix and quantity of products we sell to The Home Depot and our other customers. Our financial results are dependent upon the operating costs associated with our supply chain, including materials, labor and freight, and the level of selling, distribution and administrative, research and development and other operating expense. We continuously seek to improve our existing products and bring new products to market. As a result, many of our products have short life cycles and, therefore, product life cycle planning is critical. New product introductions, if not properly coordinated with end-of life transitions, can lead to inventory write-downs and provisions for expected losses on non-cancellable purchase commitments. When these circumstances are present, we may also incur additional expense as we adjust our supply chain and product life-cycle planning.

Non-GAAP Financial Measures

Although our condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”), we believe the following non-GAAP financial measures provide additional information that is useful to the assessment of our operating performance and trends. As part of our ongoing review of financial information related to our business, we regularly use non-GAAP measures, particularly non-GAAP adjusted gross margin and non-GAAP adjusted operating expense as a percentage of revenue, as we believe they provide meaningful insight into our business and useful information with respect to the results of our operations. These non-GAAP financial measures are not in accordance with, nor are they a substitute for, the comparable GAAP financial measures, and are intended to supplement our financial results that are prepared in accordance with GAAP.

The adjusted presentation below is used by management to measure our business performance and provides useful information regarding the trend in gross margin percentage based on revenue from sales of our products to customers. Excluding the impact of the provisions for inventory write-offs, our non-GAAP gross margin was 16.1% and 16.3% for the three and six months ended June 30, 2015, respectively, compared to 8.5% and 10.5% for the three and six months ended June 30, 2014, respectively. Excluding non-cash expense for stock based compensation, restructuring expense and depreciation and amortization, total operating expense decreased by 38.2% and 40.2% for the three and six months ended June 30, 2015, respectively, while revenue increased/(decreased) 17.4% and (6.8%) compared to the three and six months ended June 30, 2014, respectively. Total non-GAAP adjusted operating expense represented 27.9% and 27.8% of revenue for the three and six months ended June 30, 2015, respectively, as compared to 53.1% and 43.4% of revenue for the three and six months ended June 30, 2014, respectively. For the six months ended June 30, 2015, the decrease in non-GAAP adjusted operating expense as a percentage of revenue was due to the decrease in operating expense, primarily driven by reductions in personnel-related expense, transportation and other selling costs.

19

	Three Months Ended June 30,						Six Months Ended June 30,
	2015			2014			2015			2014
Revenue	$	23,270,363		$	19,827,864		$	42,641,908		$	45,753,705
Cost of goods sold		19,853,828			18,826,446			36,295,125			42,061,792
Deduct:
Provisions for inventory write-offs		329,576			689,637			601,028			1,094,049
Adjusted cost of goods sold		19,524,252			18,136,809			35,694,097			40,967,743
Adjusted gross profit	$	3,746,111		$	1,691,055		$	6,947,811		$	4,785,962
Non-GAAP adjusted gross profit percentage		16.1	%		8.5	%		16.3	%		10.5	%
Total operating expense		8,651,194			12,517,538			15,517,864			24,536,569
Less:
Issuance of restricted stock and stock options for directors compensation		118,364			73,348			129,465			199,368
Non-cash stock option and restricted stock compensation expense		1,330,324			916,657			2,235,720			2,218,544
Restructuring expense		214,066			793			297,770			205,845
Depreciation and amortization		488,071			1,000,313			994,143			2,076,323
Total operating expenses, excluding stock based compensation, restructuring and depreciation and amortization	$	6,500,369		$	10,526,427		$	11,860,766		$	19,836,489
GAAP operating expenses as a percentage of revenue		37.2	%		63.1	%		36.4	%		53.6	%
Non-GAAP adjusted operating expenses as a percentage of revenue		27.9	%		53.1	%		27.8	%		43.4	%

During 2013 and the first half of 2014, we adapted our supply chain and logistics processes to improve our ability to provide more efficient service to our customers and focus our efforts on developing innovative products. We continued to make improvements in our forecasting and finished goods inventory management, continued the transition of our manufacturing processes to lower cost contract manufacturers in Asia and continued to enhance our new product innovation process.

We believe that the enhancements to our business initiated in 2013 and continued throughout 2014 improved our management and manufacturing infrastructure, expanded our ability to source components and manufacture our products internationally and positioned us for organic growth. We believe these improvements will position us to capitalize on the innovative, science based and creative engineering talent at our Melbourne, Florida headquarters, which we believe provides us with a competitive advantage. In addition to developing products targeted at mainstream retail and commercial lighting, we will look to expand our product offerings to compete across multiple industry verticals.

LED Lighting Industry Trends

There are a number of industry factors that affect our business and results of operations including, among others:

● Rate and extent of adoption of LED lighting products. Our potential for growth is driven by the rate and extent of adoption of LED lighting within the general illumination market and our ability to affect this rate of adoption. Although LED lighting is relatively new and faces significant challenges before achieving widespread adoption, it has grown in recent years. Innovations and advancements in LED lighting technology that improve product performance and reduce product cost continue to enhance the value proposition of LED lighting for general illumination and expand its potential commercial applications.

20

● External legislation and subsidy programs concerning energy efficiency. The United States and many countries in the European Union and elsewhere, among others, have already instituted, or have announced plans to institute, government regulations and programs designed to encourage or mandate increased energy efficiency in lighting. These actions include in certain cases banning the sale after specified dates of certain forms of incandescent lighting, which is advancing the adoption of more energy efficient lighting solutions such as LEDs. In addition, the growing demand for electricity is increasingly driving utilities and governmental agencies to provide financial incentives such as rebates for energy efficient lighting technologies in an effort to mitigate the need for investments in new electrical generation capacity. While this trend is generally positive for us, from time to time there have been political efforts in the United States to change or limit the effectiveness of these regulations.

● Intellectual property. LED market participants rely on patented and non-patented proprietary information relating to product development, manufacturing capabilities and other core competencies of their business. Protection and licensing of intellectual property is critical. Therefore, LED lighting industry participants often take steps such as additional patent applications, confidentiality and non-disclosure agreements as well as other security measures. To enforce or protect intellectual property rights, market participants commonly commence or threaten litigation.

● Intense and constantly evolving competitive environment. Competition in the LED lighting market is intense. Many companies have made significant investments in LED lighting development and production equipment. Traditional lighting companies and new entrants are investing in LED based lighting products as LED adoption has gained momentum. Product pricing pressures is significant and market participants often undertake pricing strategies to gain or protect market share, enhance sales of their previously manufactured products and open new applications to LED based lighting solutions. To remain competitive, market participants must continuously increase product performance and reduce costs.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and consolidated results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of our condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expense and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates based upon historical experience and various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Our actual results may differ from these estimates.

A critical accounting policy is defined as one that is both material to the presentation of our financial statements and requires management to make difficult, subjective or complex judgments that could have a material effect on our financial condition and results of operations. Specifically, critical accounting estimates have the following attributes: (i) they require us to make assumptions about matters that are highly uncertain at the time of the estimate; and (ii) different estimates we could reasonably have used, or changes in the estimate that are reasonably likely to occur, would have a material effect on our financial condition or results of operations.

Estimates and assumptions about future events and their effects cannot be determined with certainty. We base our estimates on historical experience and on various other assumptions believed to be applicable and reasonable under the circumstances. These estimates may change as new events occur, as additional information is obtained and as our operating environment changes. These changes have historically been minor and have been included in the financial statements as soon as they became known.

We believe that our critical accounting policies relate to our more significant estimates and judgments used in the preparation of our condensed consolidated financial statements. Our Annual Report on Form 10-K for the year ended December 31, 2014 contains a discussion of these critical accounting policies. There have been no significant changes in our critical accounting policies since December 31, 2014. See also Note 1 to our unaudited condensed consolidated financial statements for the three and six months ended June 30, 2015 as set forth herein.

21

RESULTS OF OPERATIONS 

Three Months Ended June 30, 2015 Compared to the Three Months Ended June 30, 2014

The following table sets forth statement of operations data expressed as a percentage of total revenue for the periods indicated:

		Three Months Ended June 30,					Variance				Percentage of Revenue
		2015			2014		$		%		2015		2014
Revenue	$	23,270,363		$	19,827,864		3,442,499		17.4	%	100.0	%	100.0	%
Cost of goods sold		19,853,828			18,826,446		1,027,382		5.5	%	85.3	%	94.9	%
Selling, distribution and administrative		6,896,060			9,981,850		(3,085,790	)	-30.9	%	29.6	%	50.3	%
Research and development		1,052,997			1,534,582		(481,585	)	-31.4	%	4.5	%	7.7	%
Restructuring expense		214,066			793		213,273		26894.5	%	0.9	%	0.0	%
Depreciation and amortization		488,071			1,000,313		(512,242	)	-51.2	%	2.1	%	5.0	%
Interest income		1,163			225		938		416.9	%	0.0	%	0.0	%
Interest expense, including related party		(1,728,938	)		(2,140,861	)	411,923		-19.2	%	-7.4	%	-10.8	%
Increase in fair value of liabilities under derivative contracts		4,595,279			1,983,150		2,612,129		131.7	%	19.7	%	10.0	%
Other (expense) income, net		(77,158	)		45,090		(122,248	)	-271.1	%	-0.3	%	0.2	%
Net loss	$	(2,444,313	)	$	(11,628,516	)	9,184,203		-79.0	%	-10.5	%	-58.6	%

Revenue

Revenue increased $3.4 million, or 17.4%, to $23.3 million for the three months ended June 30, 2015 from $19.8 million for the three months ended June 30, 2014. The increase in revenue was primarily a result of a $7.4 million increase in sales to The Home Depot, partially offset by a $4.0 million decrease in sales to multiple other customers for the three months ended June 30, 2015 as compared to sales for the three months ended June 30, 2014. The increase in sales to The Home Depot during the three months ended June 30, 2015 was partially driven by our delivery of products during the period that were originally scheduled for delivery during the three months ended March 31, 2015, but were delayed due to port disruptions and harsh winter weather.

Cost of Goods Sold

Cost of goods sold increased $1.0 million, or 5.5%, to $19.9 million for the three months ended June 30, 2015 from $18.8 million for the three months ended June 30, 2014. The increase in cost of goods sold was primarily due to the increase in revenue. Cost of goods sold as a percentage of revenue decreased for the three months ended June 30, 2015 to 85.3% (or a gross margin percentage of 14.7%) as compared to 94.9% (or a gross margin percentage of 5.1%) for the three months ended June 30, 2014. The increase in the gross margin for the three months ended June 30, 2015 compared to the three months ended June 30, 2014 was due primarily to the impact of our transition to lower cost contract manufacturers in Asia.

Selling, Distribution and Administrative

Selling, distribution and administrative expense decreased $3.1 million, or 30.9%, to $6.9 million for the three months ended June 30, 2015 from $10.0 million for the three months ended June 30, 2014, and decreased as a percentage of revenue to 29.6% for the three months ended June 30, 2015 from 50.3% for the three months ended June 30, 2014. The decrease in selling, distribution and administrative expense consisted of a $1.6 million decrease in personnel-related expense due to the workforce reductions in 2014 and 2015, an $800,000 decrease in fees paid to outside consultants and agents, a $577,000 decrease in facilities related expenses due to our move to a new location, a $267,000 decrease in freight and logistics, a decrease of $224,000 due to miscellaneous cost cutting measures, and a $163,000 decrease in personnel costs due to the winding down of our operations in Mexico, India and the Netherlands partially offset by a $522,000 increase in professional fees.

Research and Development

Research and development expense decreased $482,000, or 31.4%, to $1.1 million for the three months ended June 30, 2015 from $1.5 million for the three months ended June 30, 2014, and decreased as a percentage of revenue to 4.5% for the three months ended June 30, 2015 from 7.7% for the three months ended June 30, 2014. The decrease in research and development expense was primarily due to a $427,000 decrease in personnel related expense driven by the workforce reductions in 2014 and 2015.

22

Restructuring

Restructuring expense was $214,000 for the three months ended June 30, 2015 compared to $1,000 for the three months ended June 30, 2014. Restructuring expense for the three months ended June 30, 2015 consisted of severance and termination benefits. Restructuring expense for the three months ended June 30, 2014 consisted of $1,000 related to the winding down of our Indian subsidiary.

Depreciation and Amortization

Depreciation and amortization expense decreased $512,000, or 51.2%, to $488,000 for the three months ended June 30, 2015 from $1.0 million for the three months ended June 30, 2014. The decrease in depreciation and amortization expense was primarily a result of the disposal or impairment of manufacturing equipment and tools and molds during the year ended December 31, 2014 related to our restructuring efforts, which included a broad based reduction of facilities and personnel, resulting in a smaller depreciable base for the current period.

Interest Expense, Including Related Party

Interest expense, including related party interest, decreased $412,000, or 19.2%, to $1.7 million for the three months ended June 30, 2015 from $2.1 million for the three months ended June 30, 2014. The decrease in interest expense was primarily due to the impact of the Company’s five-year term loan (as amended from time to time, the “Medley Term Loan”) with Medley Capital Corporation (“Medley”). Interest expense for the three months ended June 30, 2015 consisted of $1.2 million of interest expense and fees related to the Medley Term Loan, $138,000 of non-cash interest expense related to the amortization of the Pegasus Guaranty (as defined below) and $338,000 of interest expense and fees related to the three year asset based revolving credit facility (as amended from time to time, the “FCC ABL”) entered into on April 25, 2014 with ACF Finco I LP (as assignee of First Capital) Interest expense for the three months ended June 30, 2014 consisted of $1.9 million of interest expense and fees related to the Medley Term Loan, $138,000 of non-cash interest expense related to the amortization of the Pegasus Guaranty, $130,000 of interest expense and fees related to the FCC ABL.

Increase in Fair Value of Liabilities under Derivative Contracts

On February 19, 2014, in connection with the consummation of the transactions contemplated by the Medley Loan Agreement, we issued a warrant to purchase 5,000,000 shares of our common stock, par value $0.001 per share (the “Common Stock”) to each of Medley and Medley Opportunity Fund II LP (the “Medley Warrants”). The Medley Warrants were accounted for as liabilities and their fair value was determined using the Black Scholes valuation method. Pegasus Capital Partners IV, L.P. and Pegasus Capital Partners V, L.P. (collectively, the “Pegasus Guarantors”) have agreed to provide a guaranty of our obligations under the Medley Loan Agreement in favor of Medley (the “Pegasus Guaranty”). As consideration for the Pegasus Guaranty, on February 19, 2014, we issued a warrant to purchase 5,000,000 shares of Common Stock to each of the Pegasus Guarantors (the “Pegasus Guaranty Warrants”). The Pegasus Guaranty Warrants were accounted for as liabilities and their fair value was determined using the Black Scholes valuation method. The fair value of the outstanding Medley Warrants and the Pegasus Guaranty Warrants decreased by $531,000 for the three months ended June 30, 2015 and decreased by $428,000 for the three months ended June 30, 2014. This change in fair value is impacted by a number of factors, including changes in the trading price of our Common Stock and changes in risk-free interest rates.

On September 11, 2013, we issued shares of our Series J Convertible Preferred Stock (“Series J Preferred Stock”) to LSGC Holdings II LLC (“Holdings II”) and certain other purchasers and issued a warrant to Holdings II (the “Pegasus Warrant”). The Pegasus Warrant was accounted for as a liability and its fair value was determined using the Monte Carlo valuation method. On May 25, 2012, we issued shares of our Series H Convertible Preferred Stock (the “Series H Preferred Stock”) to RW LSG Holdings LLC, an affiliate of Riverwood LSG Management Holdings LLC and Riverwood Capital Partners L.P. (collectively with their affiliates, “Riverwood”), and certain other purchasers and issued warrants to Riverwood (the “Riverwood Warrant”). The Riverwood Warrant was accounted for as a liability and its fair value was determined using the Monte Carlo valuation method. The fair value of the outstanding Pegasus Warrant and the Riverwood Warrant decreased by $3.8 million for the three months ended June 30, 2015 and decreased by $562,000 for the three months ended June 30, 2014. These changes in fair value are impacted by a number of factors, including the change of the strike price of the Riverwood Warrant and the Pegasus Warrant due to the issuance of the Series J Preferred Stock and Series J Warrants, changes in the trading price of our Common Stock and changes in risk-free interest rates.

23

Between January 3, 2014 and March 7, 2014, we issued an aggregate of 17,475 units of our securities (the “Series J Securities”) with each Series J Security consisting of (i) one share of our Series J Preferred Stock and (ii) a warrant to purchase 2,650 shares of our Common Stock at an exercise price of $0.001 per share (the “Series J Warrants”). The Series J Warrants issued as part of the Series J Securities were accounted for as liabilities through April 14, 2014, the effective date of an amendment to our Certificate of Incorporation increasing the authorized number of shares of Common Stock (the “Charter Amendment”), at which point the Series J Warrants were deemed equity instruments. While the Series J Warrants were accounted for as a liability their fair value was determined using the Black Scholes valuation method. The change in fair value of the Series J Warrants was $994,000 for the period from April 1, 2014 to April 14, 2014, which was included in the (increase) decrease in fair value of liabilities under derivative contracts in the consolidated statement of operations and comprehensive loss.

Other (Expense) Income, Net

Other (expense) income, net decreased $122,000 for the three months ended June 30, 2015 to an expense of $77,000 compared to income of $45,000 for the three months ended June 30, 2014. Other expense for the three months ended June 30, 2015 consisted of a $77,000 foreign exchange loss. Other income for the three months ended June 30, 2014 consisted of a $38,000 foreign exchange gain and $7,000 of miscellaneous income.

Six Months Ended June 30, 2015 Compared to the Six Months Ended June 30, 2014 

		Six Months Ended June 30,					Variance				Percentage of Revenue
		2015			2014		$		%		2015		2014
Revenue	$	42,641,908		$	45,753,705		(3,111,797	)	-6.8	%	100.0	%	100.0	%
Cost of goods sold		36,295,125			42,061,792		(5,766,667	)	-13.7	%	85.1	%	91.9	%
Selling, distribution and administrative		11,991,641			19,175,795		(7,184,154	)	-37.5	%	28.1	%	41.9	%
Research and development		2,234,310			3,078,606		(844,296	)	-27.4	%	5.2	%	6.7	%
Restructuring expense		297,770			205,845		91,925		44.7	%	0.7	%	0.4	%
Depreciation and amortization		994,143			2,076,323		(1,082,180	)	-52.1	%	2.3	%	4.5	%
Interest income		1,163			636		527		82.9	%	0.0	%	0.0	%
Interest expense, including related party		(3,329,598	)		(3,484,086	)	154,488		-4.4	%	-7.8	%	-7.6	%
(Increase) decrease in fair value of liabilities under derivative contracts		(3,505,493	)		(27,496,388	)	23,990,895		*		-8.2	%	-60.1	%
Other (expense) income, net		(40,394	)		102,015		(142,409	)	-139.6	%	-0.1	%	0.2	%
Net loss	$	(16,045,403	)	$	(51,722,479	)	35,677,076		-69.0	%	-37.6	%	-113.0	%

* Variance is not meaningful.

Revenue

Revenue decreased $3.1 million, or 6.8%, to $42.6 million for the six months ended June 30, 2015 from $45.8 million for the six months ended June 30, 2014. The decrease in revenue was primarily a result of a $6.0 million decrease in sales to multiple customers other than The Home Depot for the six months ended June 30, 2015 compared to sales for the six months ended June 30, 2014, with a $2.8 million offsetting increase in sales to The Home Depot.

Cost of Goods Sold

Cost of goods sold decreased $5.8 million, or 13.7%, to $36.3 million for the six months ended June 30, 2015 from $42.1 million for the six months ended June 30, 2014. The decrease in cost of goods sold was partially due to the corresponding decrease in revenue during the six months ended June 30, 2015 as well as the impact of our transition to lower cost contract manufacturers in Asia.

Cost of goods sold as a percentage of revenue decreased for the six months ended June 30, 2015 to 85.1% (or gross margin of 14.9%) as compared to 91.9% (or gross margin of 8.1%) for the six months ended June 30, 2014. The decrease in cost of goods sold as a percentage of revenue was primarily affected by the impact of our transition to lower cost contract manufacturers in Asia during the six months ended June 30, 2015 compared to the six months ended June 30, 2014.

Selling, Distribution and Administrative

Selling, distribution and administrative expense decreased $7.2 million, or 37.5%, to $12.0 million for the six months ended June 30, 2015 from $19.2 million for the six months ended June 30, 2014, and decreased as a percentage of revenue to 28.1% for the six months ended June 30, 2015 from 41.9% for the six months ended June 30, 2014. The decrease in selling, distribution and administrative expense consisted of a $2.8 million decrease in personnel related expense due to the workforce reductions in in 2014 and 2015, a $2.0 million decrease in fees paid to outside consultants and agents, a $990,000 decrease in facilities related expenses due to our move to a new location, a $618,000 decrease in freight and logistics, a $417,000 decrease in personnel costs due to the winding down of our operations in Mexico, India and the Netherlands and a decrease of $363,000 due to miscellaneous cost cutting measures.

24

Research and Development

Research and development expense decreased $844,000, or 27.4%, to $2.2 million for the six months ended June 30, 2015 from $3.1 million for the six months ended June 30, 2014, and decreased as a percentage of revenue to 5.2% for the six months ended June 30, 2015 from 6.7% for the six months ended June 30, 2014. The decrease in research and development expense was primarily due to a $574,000 decrease in personnel related expense due to the workforce reductions in 2014 and 2015, a $132,000 decrease in fees paid to outside consultants and a decrease of $140,000 due to miscellaneous cost cutting measures.

Restructuring Expense

Restructuring expense increased $92,000 to $298,000 for the six months ended June 30, 2015 from $206,000 for the six months ended June 30, 2014. Restructuring expense for the six months ended June 30, 2015 consisted of severance and termination benefits related to additional headcount reductions in the United States. Restructuring expense for the six months ended June 30, 2014 consisted of $182,000 in severance and termination benefits related to additional headcount reductions in the United States and a net charge of $114,000 related to the final liquidation of our Australian subsidiary, partially offset by a reduction in estimated costs related to the winding down of our Indian subsidiary.

Depreciation and Amortization

Depreciation and amortization expense decreased $1.1 million, or 52.1%, to $994,000 for the six months ended June 30, 2015 from $2.1 million for the six months ended June 30, 2014, and decreased as a percentage of revenue to 2.3% for the six months ended June 30, 2015 from 4.5% for the six months ended June 30, 2014. The decrease in depreciation and amortization expense was primarily a result of the disposal or impairment of manufacturing equipment and tools and molds during the year ended December 31, 2014 related to our restructuring efforts, which included a broad based reduction of facilities and personnel, resulting in a smaller depreciable base for the current period.

Interest Expense, Including Related Party

Interest expense, including related party interest, decreased $155,000, or 4.4%, to $3.3 million for the six months ended June 30, 2015 from $3.5 million for the six months ended June 30, 2014. The decrease in interest expense was primarily due to the impact of the Medley Term Loan and the FCC ABL replacing our previous credit facilities with Wells Fargo Bank N.A. (the “Wells Fargo ABL”) and the Ares Capital Corporation (the “Ares Letter of Credit Facility”). Interest expense for the six months ended June 30, 2015 consisted of $2.5 million of interest expense and fees related to the Medley Term Loan, $277,000 non-cash interest expense related to the amortization of the Pegasus Guaranty and $563,000 of interest expense and fees related to the FCC ABL. Interest expense for the six months ended June 30, 2014 consisted of $2.5 million of interest expense and fees related to the Medley Term Loan, $200,000 of non-cash interest expense related to the amortization of the Pegasus Guaranty, $264,000 of interest expense and fees related to the Wells Fargo ABL, $426,000 of interest expense related to the Ares Letter of Credit Facility and $130,000 of interest expense and fees related to the FCC ABL.

(Increase) Decrease in Fair Value of Liabilities under Derivative Contracts

The fair value of the outstanding Medley Warrants and the Pegasus Guaranty Warrants increased by $1.9 million for the six months ended June 30, 2015 and decreased by $271,000 for the period from February 19, 2014 (the date of issuance of the Medley and Pegasus Guaranty Warrants) to June 30, 2014. This change in fair value is impacted by a number of factors, including changes in the trading price of our Common Stock and changes in risk-free interest rates.

The fair value of the outstanding Pegasus Warrant and the Riverwood Warrants increased by $1.6 million for the six months ended June 30, 2015 and increased by $2.6 million for the six months ended June 30, 2014. These changes in fair value are impacted by a number of factors, including the change of the strike price of the Riverwood Warrants due to the issuance of the Series J Preferred Stock and Series J Warrants, changes in the trading price of our Common Stock and changes in risk-free interest rates.

25

The change in fair value of the Series J Warrants was $25.1 million for the period from date of issuance of the Series J Warrants to April 14, 2014, which was included in the (increase) decrease in fair value of liabilities under derivative contracts in the consolidated statement of operations and comprehensive loss for the six months ended June 30, 2014. This change in fair value is impacted primarily by the valuation of the Series J Warrants as of June 30, 2014 based on the Black Scholes valuation method as compared to fair value at date of issuance based on an allocation of the cash received for the Series J Securities between the Series J Preferred Stock and the Series J Warrants.

Other (Expense) Income, Net

Other (expense) income, net decreased $142,000 for the six months ended June 30, 2015 to net expense of $40,000 from net income of $102,000 for the six months ended June 30, 2014. Other expense for the six months ended June 30, 2015 consisted of a $166,000 foreign exchange loss and $25,000 in miscellaneous expense, partially offset by $152,000 of miscellaneous income. Other income for the six months ended June 30, 2014 consisted of an $82,000 foreign exchange gain and $21,000 of miscellaneous income.

Liquidity and Capital Resources

We continue to experience significant net losses as well as negative cash flows from operations, resulting in an accumulated deficit of $816.4 million and stockholders’ deficit of $512.3 million as of June 30, 2015. As of June 30, 2015, we had cash and cash equivalents of $347,000 and an additional $3.0 million in restricted cash subject to a cash collateral dominion agreement pursuant to the Medley Term Loan. Our cash expenditures primarily relate to procurement of inventory and payment of salaries, benefits and other operating costs.

Our primary sources of liquidity have historically been borrowings from various lenders and sales of Common Stock and Preferred Stock to, and short-term loans from, affiliates of Pegasus Capital Advisors, L.P. (“Pegasus Capital”), including Pegasus Partners IV, L.P. (“Pegasus IV”), LSGC Holdings LLC (“LSGC Holdings”), Holdings II, LSGC Holdings III LLC (“Holdings III”) and PCA LSG Holdings, LLC (“PCA Holdings” and collectively with Pegasus Capital, Pegasus IV, LSGC Holdings, Holdings II, Holdings III and their affiliates, “Pegasus”). Pegasus is the Company’s controlling stockholder. While Pegasus has led many of our capital raises, the offerings of our Series H Preferred Stock, Series I Convertible Preferred Stock (the “Series I Preferred Stock”) and Series J Preferred Stock also involved and/or were led by parties other than Pegasus.

The FCC ABL provides us with a maximum borrowing capacity of $22.5 million, which capacity is based on a formula of eligible accounts receivable and inventory. We are also required to achieve a minimum quarterly fixed charge coverage ratio for the preceding 12-month period under the FCC ABL. As of June 30, 2015, we had $11.2 million outstanding under the FCC ABL and additional borrowing capacity of $2.0 million.

On January 30, 2015, we issued an additional 11,525 units of our Series J Securities, at a purchase price of $1,000 per Series J Security for aggregate proceeds of $11.5 million. These Series J Securities were issued pursuant to a subscription agreement with Holdings III.

Commencing on September 25, 2015, Riverwood and Pegasus will have the right to cause us to redeem their shares of Series H Preferred Stock and Series I Preferred Stock, respectively. If either Riverwood or Pegasus elects to cause us to redeem its shares of Series H Preferred Stock or Series I Preferred Stock, all other holders of the applicable series will similarly have the right to request the redemption of their shares of Series H Preferred Stock or Series I Preferred Stock, respectively. In addition, commencing 10 business days after September 25, 2015, Portman Limited and affiliates of Zouk Holdings Limited, acting together have a contractual right to require us to redeem their respective shares of Series H Preferred Stock. We are also required to redeem the outstanding shares of our Series J Preferred Stock (a) subject to certain limited exceptions, immediately prior to the redemption of the Series H Preferred Stock, Series I Preferred Stock or any other security that ranks junior to, or pari passu with, the Series J Preferred Stock and (b) on November 14, 2019, at the election of the holders of Series J Preferred Stock (a “Special Redemption”). Holders of our Preferred Stock would also have the right to require us to redeem such shares upon our uncured material breach of our obligations under our outstanding indebtedness or the uncured material breach of the terms of the certificates of designation governing the Preferred Stock. As of June 30, 2015, in the event we were required to redeem all of our outstanding shares of Preferred Stock, our maximum payment obligation would have been $492.0 million. We would be required to repay our outstanding obligations under the Medley Term Loan and the FCC ABL prior to any such redemption of shares of Series H, I or J Preferred Stock. As of June 30, 2015, the aggregate borrowings outstanding under these loan facilities was $39.7 million.

26

Any redemption of the Series H Preferred Stock, Series I Preferred Stock or Series J Preferred Stock would be limited to funds legally available therefor under Delaware law. The certificates of designation governing the Preferred Stock provide that if there is not a sufficient amount of cash or surplus available to pay for a redemption of Series H Preferred Stock, Series I Preferred Stock or Series J Preferred Stock, then the redemption must be paid out of the remaining assets of the Company. In addition, the certificates of designation provide that we are not permitted or required to redeem any shares of Preferred Stock for so long as such redemption would result in an event of default under our credit facilities.

As of June 30, 2015, based solely on a review of our balance sheet, we did not have legally available funds under Delaware law to satisfy a redemption of our Preferred Shares. In addition, based solely on our projected balance sheet as of September 25, 2015, we do not believe that we will have legally available funds on or before September 25, 2015 to satisfy any such redemption.

The certificate of designation governing the Series H Preferred Stock also provides that upon the occurrence of a “control event,” we must take any and all actions required and permitted to fix the size of our board of directors to a size that would permit Riverwood (as the primary investor of the Series H Preferred Stock) to appoint a majority of the directors to the board until we satisfy or otherwise cure the obligations giving rise to the control event. A control event occurs if, among other things, Riverwood exercises its optional redemption right under the certificate of designation governing the Series H Preferred Stock and we are unable to redeem Riverwood’s Preferred Stock. If Riverwood were to exercise its optional redemption right and a control event were to occur, Riverwood could take control of the board of directors. In addition, if we do not have sufficient capital available to redeem the Series J Preferred Stock in connection with a Special Redemption of the Series J Preferred Stock, we will be required to issue a non-interest bearing note or notes (payable 180 days after issuance) in the principal amount of the liquidation amount of any shares of Series J Preferred Stock not redeemed by the Company in connection with such Special Redemption, subject to certain limitations imposed by Delaware law governing distributions to stockholders.

As discussed further in Note 14 to our unaudited condensed consolidated financial statements for the three and six months ended June 30, 2015, one of our stockholders, Geveran Investments Limited (“Geveran”), filed a lawsuit against us and certain other defendants seeking, among other things, rescission of its $25.0 million investment in the Company. On August 28, 2014, the court presiding over the lawsuit granted Geveran’s motion for partial summary judgment with respect to its cause of action for violation of the Florida securities laws. As of June 30, 2015, the order relating to the judgment had not been entered. Although we cannot predict the ultimate outcome of this lawsuit, we believe the court’s summary judgment award in favor of Geveran is in error and that we have strong defenses against Geveran’s claims. In the event that we are not successful on appeal, we could be liable for Geveran’s $25.0 million investment, as well as interest, attorneys’ fees and court costs. After the order is entered, we plan to appeal and, together with the other defendants, post a bond, which would allow us to obtain an automatic stay of enforcement throughout the appeal process. The summary judgment order and the bond required to stay enforcement of the judgment could have an adverse effect on our liquidity and our ability to raise capital in the future.

We continue to face challenges in our efforts to achieve positive cash flows from operations and profitability. Our ability to continue to meet our obligations in the ordinary course of business is dependent upon establishing profitable operations, which may be supplemented by any additional funds raised through public or private financing or increased borrowing capacity. As a result of our historical and continuing losses, we believe we will likely need to raise additional capital to fund our ongoing operations. There can be no assurance that sources of additional capital will be available in an amount or on terms that are acceptable to us, if at all. If we are not able to raise such additional capital, we may need to restructure or refinance our existing obligations, which restructuring or refinancing would require the consent and cooperation of our creditors. In such event, there can be no assurance that such restructuring or refinancing could be accomplished on terms that are acceptable to us, if at all

Our supply agreement with The Home Depot, the term of which continues until July 23, 2016, does not require The Home Depot to purchase any minimum amount of products from us. Moreover, The Home Depot performs periodic product line reviews to assess its product offerings, which can lead to pricing pressures and/or a reallocation of its business to other suppliers. In June 2015, The Home Depot performed its most recent product line review which covered its entire private label LED lighting product offering. Although we have not been advised of the results of this product line review, such review could result in a material loss of revenue from sales to The Home Depot.

As a result of our historical and continuing losses, we believe we will likely need to raise additional capital to fund our ongoing operations. There can be no assurance that sources of additional capital will be available in an amount or on terms that are acceptable to us, if at all. If we are not able to raise such additional capital, we may need to restructure or refinance our existing obligations, which restructuring or refinancing would require the consent and cooperation of our creditors and certain stockholders. In such event, there can be no assurance that such restructuring or refinancing could be accomplished on terms that are acceptable to us, if at all

27

Cash Flows

The following table summarizes our cash flow activities for the six months ended June 30, 2015 and 2014:

	Six Months Ended June 30,
Cash flow activities:	2015			2014
Net cash used in operating activities	$	(17,042,419	)	$	(23,115,504	)
Net cash used in investing activities		(256,958	)		(348,553	)
Net cash provided by financing activities		15,975,186			12,837,122

Operating Activities

Cash used in operating activities is net loss adjusted for certain non-cash items and changes in certain assets and liabilities. Net cash used in operating activities decreased to $17.0 million for the six months ended June 30, 2015 from $23.1 million for the six months ended June 30, 2014. Net cash used in operating activities for the six months ended June 30, 2015 included certain non-cash reconciliation items comprised primarily of a $3.5 million net increase in fair value of derivative contracts, $2.4 million of stock-based compensation expense, $1.3 million in amortization of debt issuance costs, accretion and interest accrual primarily on the FCC ABL and the Medley Term Loan, $994,000 in depreciation and amortization and $485,000 in inventory write-downs. For the six months ended June 30, 2014, net cash used in operating activities included certain non-cash reconciliation items comprised primarily of a $27.5 million increase in fair value of derivative contracts, $2.4 million of stock-based compensation expense, $2.1 million in depreciation and amortization, a $1.1 million inventory write-down and a $1.5 million in amortization of debt issuance costs, accretion and interest accrual primarily on the FCC ABL and the Medley Term Loan.

Changes in working capital also contributed to the decrease in net cash used in operating activities for the six months ended June 30, 2015 as compared to the six months ended June 30, 2014. In the aggregate, working capital changes totaled a net use of cash of $9.2 million in the six months ended June 30, 2015 compared to a net use of cash of $5.9 million in the six months ended June 30, 2014. For the six months ended June 30, 2015, the working capital changes consisted primarily of a decrease in accounts payable of $11.2 million, which was partially offset by a decrease in inventories of $2.2 million. For the six months ended June 30, 2014 the working capital changes consisted primarily of an increase in inventories of $6.1 million, which was partially offset by a $1.2 million decrease accounts receivable.

Investing Activities

Cash used in investing activities primarily relates to the purchase of property and equipment and capitalized patents. Net cash used in investing activities was $257,000 and $349,000 for the six months ended June 30, 2015 and 2014, respectively. The cash used in investing activities for the six months ended June 30, 2015 was primarily due to capitalized patents of $221,000. The cash used in investing activities for the six months ended June 30, 2014 was due to capitalized patents of $461,000 and purchases of property and equipment of $262,000, partially offset by proceeds from sale of property and equipment of $375,000.

Financing Activities

Cash provided by financing activities has historically been composed of net proceeds from various debt facilities and the issuance of Common Stock and preferred stock. Net cash provided by financing activities was $16.0 million and $12.8 million for the six months ended June 30, 2015 and 2014, respectively. The cash provided by financing activities for the six months ended June 30, 2015 included proceeds from the issuance of Series J Securities in January 2015 for aggregate proceeds of $11.5 million and net draws on our lines of credit and other short term borrowings of $4.8 million, partially offset by $184,000 in debt issuance costs and $148,000 in fees incurred in connection with the issuance of Series J Securities. The cash provided by financing activities for the six months ended June 30, 2014 included proceeds of $29.8 million on the Medley Term Loan and the issuance of Series J Preferred Stock for $17.5 million, partially offset by net payments on our lines of credit and other short term borrowings, including the repayment of $32.7 million on the Wells Fargo ABL, the Ares Letter of Credit Facility, the Medley Term Loan and the FCC ABL, $3.2 million in debt issuance costs and $485,000 in fees and commissions paid in connection with the issuance of Series J Securities.

28

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”)) that are designed to provide reasonable assurance that the information required to be disclosed by us in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our Chief Executive Officer (who is also our Principal Financial and Accounting Officer at this time (the “Certifying Officer”)), as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

We carried out an evaluation under the supervision and with the participation of our management, including the Certifying Officer, of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this quarterly report. Based on that evaluation, our management, including the Certifying Officer, concluded that, as of June 30, 2015, our disclosure controls and procedures were not effective at a reasonable assurance level because the remediation plans to address the material weaknesses identified in our Annual Report on Form 10-K for the year ended December 31, 2014 have not been fully tested.

Changes in Internal Control over Financial Reporting

Subsequent to December 31, 2014, the following are among the key actions taken to our internal controls, which have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting:

● We have reemphasized the importance of consistent application of the controls over the spreadsheet formulas used in the inventory valuation and enhanced the training of the personnel responsible for preparing and reviewing the spreadsheet; and

● We have implemented a reconciliation and confirmation process for our in-transit inventory on a monthly basis, as well as provided additional training of the personnel responsible for preparing and reviewing these transactions.

Although these actions have not been fully tested, we believe we have remediated the material weaknesses described in our Annual Report on Form 10-K for the year ended December 31, 2014.

Our leadership team, together with other senior executives and our board of directors, is committed to achieving and maintaining a strong control environment, high ethical standards and financial reporting integrity. This commitment has been and will continue to be communicated to, and reinforced with, our employees. Under the direction of our board of directors, management will continue to review and make changes to the overall design of our internal control environment, as well as policies and procedures to improve the overall effectiveness of our internal control over financial reporting and our disclosure controls and procedures.

Other than the measures discussed above, there were no changes in our internal control over financial reporting that occurred during the quarter ended June 30, 2015 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

Except as listed below, other items in Part II are omitted because the items are inapplicable or require no response.

Item 1. Legal Proceedings

For a description of material pending legal proceedings, see the discussion set forth under the heading “Legal Proceedings” in Note 14 to our unaudited condensed consolidated financial statements for the three and six months ended June 30, 2015, which discussion is incorporated by reference herein.

Item 6. Exhibits

 See “Exhibit Index” for a description of our exhibits.

29

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	LIGHTING SCIENCE GROUP CORPORATION
Date: August 12, 2015	By	/s/ Edward D. Bednarcik
	Edward D. Bednarcik
	Chief Executive Officer and Director
	(Principal Executive, Financial and Accounting Officer)

30

Exhibit Index

EXHIBIT NUMBER	DESCRIPTION
3.1	Amended and Restated Certificate of Incorporation of Lighting Science Group Corporation (previously filed as Exhibit 3.1 to the Annual Report on Form 10-K filed on March 31, 2015, File No. 0-20354, and incorporated herein by reference).
3.2	Amended and Restated Bylaws of Lighting Science Group Corporation (previously filed as Exhibit 3.1 to the Current Report on Form 8-K filed on December 28, 2010, File No. 0-20354, and incorporated herein by reference).
3.3	Certificate of Amendment to Amended and Restated Certificate of Incorporation (previously filed as Exhibit 3.3 to the Annual Report on Form 10-K filed on March 31, 2015, File No. 0-20354, and incorporated herein by reference).
4.1	Specimen Common Stock Certificate (previously filed as Exhibit 4.14 to Amendment No. 1 to the Registration Statement on Form S-1/A filed on January 12, 2010, File No. 333-162966, and incorporated herein by reference).
4.2	Amended and Restated Certificate of Designation of Series H Convertible Preferred Stock filed with the Secretary of State of Delaware on November 14, 2014 (previously filed as Exhibit 4.1 to the Current Report on Form 8-K filed on November 20, 2014, File No. 0-20354, and incorporated herein by reference).
4.3	Amended and Restated Certificate of Designation of Series I Convertible Preferred Stock filed with the Secretary of State of Delaware on November 14, 2014 (previously filed as Exhibit 4.2 to the Current Report on Form 8-K filed on November 20, 2014, File No. 0-20354, and incorporated herein by reference).
4.4	Amended and Restated Certificate of Designation of Series J Convertible Preferred Stock filed with the Secretary of State of Delaware on November 14, 2014 (previously filed as Exhibit 4.3 to the Current Report on Form 8-K filed on November 20, 2014, File No. 0-20354, and incorporated herein by reference).
4.5	Warrant Agreement, dated as of December 22, 2010, by and between Lighting Science Group Corporation and American Stock Transfer & Trust Company, LLC (previously filed as Exhibit 4.1 to the Current Report on Form 8-K filed on January 4, 2011, File No. 0-20354, and incorporated herein by reference).
4.6	Warrant to Purchase Common Stock of Lighting Science Group Corporation, dated January 13, 2011 and issued to The Home Depot, Inc. (previously filed as Exhibit 4.1 to the Current Report on Form 8-K filed on January 20, 2011, File No. 0-20354, and incorporated herein by reference).

31

EXHIBIT NUMBER	DESCRIPTION
4.7	Form of Warrant to Purchase Common Stock of Lighting Science Group Corporation, dated June 15, 2012 and issued to RW LSG Management Holdings LLC and certain other investors (previously filed as Exhibit 4.6 to Amendment No. 2 to the Registration Statement on Form S-1/A filed on September 27, 2012, File No. 333-172165, and incorporated herein by reference).
4.8	Warrant, dated as of September 25, 2012 and issued to Cleantech Europe II (A) LP (previously filed as Exhibit 4.1 to the Current Report on Form 8-K filed on September 27, 2012, File No. 0-20354, and incorporated herein by reference).
4.9	Warrant, dated as of September 25, 2012 and issued to Cleantech Europe II (B) LP (previously filed as Exhibit 4.2 to the Current Report on Form 8-K filed on September 27, 2012, File No. 0-20354, and incorporated herein by reference).
4.10	Warrant, dated as of September 25, 2012 and issued to Portman Limited (previously filed as Exhibit 4.3 to the Current Report on Form 8-K filed on September 27, 2012, File No. 0-20354, and incorporated herein by reference).
4.11	Warrant, dated as of September 11, 2013, by and between Lighting Science Group Corporation and LSGC Holdings II LLC (previously filed as Exhibit 4.4 to the Current Report on Form 8-K filed on September 13, 2013, File No. 0-20354, and incorporated herein by reference).
4.12	Warrant, dated as of January 3, 2014, by and between Lighting Science Group Corporation and LSGC Holdings II LLC (previously filed as Exhibit 4.4 to the Current Report on Form 8-K filed on January 8, 2014, File No. 0-20354, and incorporated herein by reference).
4.13	Warrant, dated as of January 3, 2014, by and between Lighting Science Group Corporation and PCA LSG Holdings LLC (previously filed as Exhibit 4.5 to the Current Report on Form 8-K filed on January 8, 2014, File No. 0-20354, and incorporated herein by reference).
4.14	Warrant, dated as of January 3, 2014, by and between Lighting Science Group Corporation and RW LSG Holdings LLC (previously filed as Exhibit 4.6 to the Current Report on Form 8-K filed on January 8, 2014, File No. 0-20354, and incorporated herein by reference).
4.15	Warrant, dated as of January 3, 2014, by and between Lighting Science Group Corporation and PCA LSG Holdings LLC (previously filed as Exhibit 4.7 to the Current Report on Form 8-K filed on January 8, 2014, File No. 0-20354, and incorporated herein by reference).
4.16	Warrant, dated as of January 3, 2014, by and between Lighting Science Group Corporation and LSGC Holdings II LLC (previously filed as Exhibit 4.8 to the Current Report on Form 8-K filed on January 8, 2014, File No. 0-20354, and incorporated herein by reference).

32

EXHIBIT NUMBER	DESCRIPTION
4.17	Warrant, dated as of January 3, 2014, by and between Lighting Science Group Corporation and RW LSG Holdings LLC (previously filed as Exhibit 4.9 to the Current Report on Form 8-K filed on January 8, 2014, File No. 0-20354, and incorporated herein by reference).
4.18	Warrant, dated as of February 19, 2014, by and between Lighting Science Group Corporation and Medley Capital Corporation (previously filed as Exhibit 4.1 to the Current Report on Form 8-K filed on February 25, 2014, File No. 0-20354, and incorporated herein by reference).
4.19	Warrant, dated as of February 19, 2014, by and between Lighting Science Group Corporation and Medley Opportunity Fund II LP (previously filed as Exhibit 4.2 to the Current Report on Form 8-K filed on February 25, 2014, File No. 0-20354, and incorporated herein by reference).
4.20	Warrant, dated as of February 19, 2014, by and between Lighting Science Group Corporation and Pegasus Capital Partners IV, L.P. (previously filed as Exhibit 4.4 to the Current Report on Form 8-K filed on February 25, 2014, File No. 0-20354, and incorporated herein by reference).
4.21	Warrant, dated as of February 19, 2014, by and between Lighting Science Group Corporation and Pegasus Capital Partners V, L.P. (previously filed as Exhibit 4.5 to the Current Report on Form 8-K filed on February 25, 2014, File No. 0-20354, and incorporated herein by reference).
4.22	Amended and Restated Registration Rights Agreement, dated as of January 23, 2009, by and between Lighting Science Group Corporation and Pegasus Partners IV, L.P. (previously filed as Exhibit 4.1 to the Current Report on Form 8-K filed on January 30, 2009, File No. 0-20354, and incorporated herein by reference).
4.22.1	Amendment to Amended and Restated Registration Rights Agreement, dated as of May 25, 2012, by and among Lighting Science Group Corporation, Pegasus Partners IV, L.P. and LSGC Holdings LLC (previously filed as Exhibit 10.5 to the Current Report on Form 8-K filed on June 1, 2012, File No. 0-20354, and incorporated herein by reference).
4.23	Registration Rights Agreement, dated January 14, 2011, between Lighting Science Group Corporation and The Home Depot, Inc. (previously filed as Exhibit 4.2 to the Current Report on Form 8-K filed on January 20, 2011, File No. 0-20354, and incorporated herein by reference).
4.24	Amended and Restated Registration Rights Agreement, dated as of September 25, 2012, by and among Lighting Science Group Corporation, RW LSG Holdings LLC, RW LSG Management Holdings LLC, Portman Limited, Cleantech Europe II (A) LP and Cleantech Europe II (B) LP (previously filed as Exhibit 10.6 to the Current Report on Form 8-K filed on September 27, 2012, File No. 0-20354, and incorporated herein by reference).

33

EXHIBIT NUMBER	DESCRIPTION
4.25	Registration Rights Agreement, dated February 19, 2014 by and between Lighting Science Group Corporation, Medley Capital Corporation and Medley Opportunity Fund II LP (previously filed as Exhibit 4.3 to the Current Report on Form 8-K filed on February 25, 2014, File No. 0-20354, and incorporated herein by reference).
4.26	Registration Rights Agreement, dated as of November 14, 2014 by and between Lighting Science Group Corporation, Serengeti Lycaon MM L.P. and Serengeti Opportunities MM L.P. (previously filed as Exhibit 10.2 to the Current Report on Form 8-K filed on November 20, 2014, File No. 0-20354, and incorporated herein by reference).
4.27	Voting Agreement, dated as of September 25, 2012, by and between Lighting Science Group Corporation and RW LSG Holdings LLC (previously filed as Exhibit 10.7 to the Current Report on Form 8-K filed on September 27, 2012, File No. 0-20354, and incorporated herein by reference).
4.28	Voting Agreement, dated as of September 25, 2012, by and among Lighting Science Group Corporation, Pegasus Capital Advisors, L.P. and LSGC Holdings II LLC (previously filed as Exhibit 10.8 to the Current Report on Form 8-K filed on September 27, 2012, File No. 0-20354, and incorporated herein by reference).
31.1*	Certification of Principal Executive Officer and Principal Financial and Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document.
101.SCH	XBRL Taxonomy Extension Schema Document.
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB	XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document.

____________________

* Filed herewith.

34

EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER PURSUANT TO RULE 13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Edward D. Bednarcik, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Lighting Science Group Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

     (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

     (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

     (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

     (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

     (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

     (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 12, 2015	By:	/s/ Edward D. Bednarcik
	Name:	Edward D. Bednarcik
	Title:	Chief Executive Officer and Director (Principal Executive, Financial and Accounting Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Lighting Science Group Corporation (the “Company”) for the period ended June 30, 2015 (the “Report”), the undersigned hereby certifies in his capacity as Principal Executive Officer and Principal Financial and Accounting Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the undersigned’s knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 12, 2015	By:	/s/ Edward D. Bednarcik
		Name:	Edward D. Bednarcik
		Title:	Chief Executive Officer and Director (Principal Executive, Financial and Accounting Officer)

XML

Note 8 - Fair Value Measurements (Details) - Financial Assets and Liabilities Accounted For at Fair Value on a Recurring Basis - Fair Value, Inputs, Level 3 [Member] - Fair Value, Measurements, Recurring [Member]	Jun. 30, 2015 USD ($)
Liabilities (Recurring):
Liabilities, Fair Value Disclosure, Recurring	$ 8,762,414
Pegasus Commitment [Member]
Assets (Recurring):
Pegasus Commitment	264,000
Riverwood Warrants [Member]
Liabilities (Recurring):
Liabilities, Fair Value Disclosure, Recurring	3,357,970
September 2012 Warrants [Member]
Liabilities (Recurring):
Liabilities, Fair Value Disclosure, Recurring	264,000
Pegasus Warrant [Member]
Liabilities (Recurring):
Liabilities, Fair Value Disclosure, Recurring	1,856,000
THD Warrant [Member]
Liabilities (Recurring):
Liabilities, Fair Value Disclosure, Recurring	207,617
Medley Warrants [Member]
Liabilities (Recurring):
Liabilities, Fair Value Disclosure, Recurring	1,489,186
Pegasus Guaranty Warrants [Member]
Liabilities (Recurring):
Liabilities, Fair Value Disclosure, Recurring	$ 1,587,641

XML

Note 12 - Restructuring Expense (Details) - Restructuring Expense and Related Charges - USD ($)		3 Months Ended		6 Months Ended
		Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		$ 214,066	$ 793	$ 297,770	$ 205,845
Facility Closing [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	[1]			$ 297,770	91,568
Organization Optimization Initiative [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	[2]				$ 114,277

[1] These charges relate to a significant cost reduction plan initiated during the fourth quarter of 2013 that includes moving the majority of the Company's manufacturing to its contract manufacturers in Asia, related workforce reductions in Satellite Beach, Florida and cost reductions in our foreign subsidiaries. The Company estimates it will incur $200,000 in additional expenses throughout this cost reduction plan, primarily related to additional headcount reductions. These additional costs are expected to be incurred during 2015.

[2] In September 2011, the Company began implementing a restructuring plan designed to further increase efficiencies across the organization and lower the overall cost structure. In 2012, the Company extended the restructuring plan to further increase efficiencies across the organization and lower its overall cost structure. The plan included a significant reduction in full time headcount and the closing of the Company's offices in the United Kingdom and Australia. For the six months ended June 30, 2014, these expenses related to the final liquidation of the Australian entity.

XML

Note 11 - Related Party Transactions (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended
	Jan. 30, 2015	Jun. 30, 2015
Pegasus Capital [Member]
Note 11 - Related Party Transactions (Details) [Line Items]
Ownership Percentage of Subsidiary Held in Parent		88.60%
Holdings III [Member] | Series J Redeemable Convertible Preferred Stock [Member]
Note 11 - Related Party Transactions (Details) [Line Items]
Preferred Units, Issued	11,525
Shares Issued, Price Per Share	$ 1,000
Proceeds from Other Equity	$ 11.5

XML

Note 4 - Detail of Certain Balance Sheet Accounts (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Disclosure Text Block Supplement [Abstract]
Inventory Write Down	$ 5,100,000		$ 5,100,000		$ 7,900,000
Depreciation	$ 467,000	$ 985,000	$ 954,000	$ 2,100,000

XML

Note 7 - Lines of Credit and Note Payable (Tables)

6 Months Ended

Jun. 30, 2015

Debt Disclosure [Abstract]

Schedule of Debt [Table Text Block]

	Balance Outstanding as of
Facility	June 30, 2015		December 31, 2014
FCC ABL, revolving line of credit	$	11,175,467	$	6,368,793
Medley Term Loan		28,516,029		27,813,061
	$	39,691,496	$	34,181,854

XML

Note 13 - Concentrations of Credit Risk (Details) - Customer Concentration Risk [Member]	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Sales Revenue, Net [Member]
Note 13 - Concentrations of Credit Risk (Details) [Line Items]
Concentration Risk, Percentage	93.00%	72.00%	87.00%	75.00%
Accounts Receivable [Member]
Note 13 - Concentrations of Credit Risk (Details) [Line Items]
Concentration Risk, Percentage			79.00%		66.00%

XML

Note 9 - Stockholders' Equity (Details) - Warrants Outstanding for Purchase of Common Stock - $ / shares	Jun. 30, 2015	Jan. 30, 2015
Class of Warrant or Right [Line Items]
Number of Common Shares	251,104,819
Series D Warrants [Member] | Investors in Rights Offering [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	1,072,617
Purchasing Agreement [Member] | The Home Depot [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	7,609,183
Exercise Price (in Dollars per share)	$ 1.05
Riverwood Warrants [Member] | RW LSG Management Holdings LLC [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	12,664,760
Riverwood Warrants [Member] | Certain Other Investors [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	5,427,751
September 2012 Warrants [Member] | Cleantech B [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	593,959
Exercise Price (in Dollars per share)	$ 0.72
September 2012 Warrants [Member] | Cleantech A [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	3,406,041
Exercise Price (in Dollars per share)	$ 0.72
September 2012 Warrants [Member] | Portman [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	4,000,000
Exercise Price (in Dollars per share)	$ 0.72
Private Placement Series H [Member] | Acquillian Investments LLC [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	830,508
Exercise Price (in Dollars per share)	$ 1.18
Pegasus Warrant [Member] | Pegasus Capital [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	10,000,000
Series J Warrants [Member]
Class of Warrant or Right [Line Items]
Exercise Price (in Dollars per share)	$ 0.001	$ 0.001
Series J Warrants [Member] | Investors in Series J Follow-on Offering [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	185,500,000
Exercise Price (in Dollars per share)	$ 0.001
Medley Warrants [Member] | Medley Capital Corporation [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	10,000,000
Exercise Price (in Dollars per share)	$ 0.95
Pegasus Guaranty Warrants [Member] | Pegasus Capital [Member]
Class of Warrant or Right [Line Items]
Number of Common Shares	10,000,000
Exercise Price (in Dollars per share)	$ 0.50
Minimum [Member] | Series D Warrants [Member] | Investors in Rights Offering [Member]
Class of Warrant or Right [Line Items]
Exercise Price (in Dollars per share)	2.95
Maximum [Member] | Series D Warrants [Member] | Investors in Rights Offering [Member]
Class of Warrant or Right [Line Items]
Exercise Price (in Dollars per share)	$ 2.96

XML

Note 7 - Lines of Credit and Note Payable (Details) - USD ($)	1 Months Ended	3 Months Ended			6 Months Ended		12 Months Ended
	Feb. 19, 2014	Jun. 30, 2015	Mar. 31, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Note 7 - Lines of Credit and Note Payable (Details) [Line Items]
Restricted Cash and Cash Equivalents, Current		$ 3,000,000			$ 3,000,000
Accretion of Discount					389,536	$ 279,167
Debt Instrument, Increase, Accrued Interest					(313,432)	(224,308)
First Capital [Member]
Note 7 - Lines of Credit and Note Payable (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		22,500,000			22,500,000
Line of Credit Facility, Remaining Borrowing Capacity		2,000,000			2,000,000
Debt Instrument, Collateral Amount		5,200,000			5,200,000		$ 5,400,000
Line of Credit Facility, Eligible Collateral Inventory		$ 8,500,000			$ 8,500,000
Debt Instrument, Interest Rate, Effective Percentage		4.18%			4.18%
First Capital [Member] | Accounts Receivable [Member]
Note 7 - Lines of Credit and Note Payable (Details) [Line Items]
Debt Instrument, Collateral Amount		$ 5,200,000			$ 5,200,000
First Capital [Member] | London Interbank Offered Rate (LIBOR) [Member]
Note 7 - Lines of Credit and Note Payable (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate					4.00%
Medley Term Loan [Member]
Note 7 - Lines of Credit and Note Payable (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		30,500,000			$ 30,500,000
Medley Term Loan [Member] | Medley Capital Corporation [Member]
Note 7 - Lines of Credit and Note Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	12.28%
Notes Payable	$ 30,500,000
Restricted Cash and Cash Equivalents, Current	$ 3,000,000
Medley Term Loan [Member] | Medley Capital Corporation [Member] | London Interbank Offered Rate (LIBOR) [Member]
Note 7 - Lines of Credit and Note Payable (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate	12.00%
Medley Term Loan [Member] | Medley Warrants [Member] | Medley Capital Corporation [Member] | Commitment Fees [Member]
Note 7 - Lines of Credit and Note Payable (Details) [Line Items]
Accretion of Discount		$ 195,000		$ 195,000	390,000	279,000
Debt Instrument, Increase, Accrued Interest			$ 155,000		$ 313,000	$ 224,000	$ 158,000

XML

Note 12 - Restructuring Expense (Details)	Jun. 30, 2015 USD ($)
Note 12 - Restructuring Expense (Details) [Line Items]
Restructuring and Related Cost, Expected Cost Remaining	$ 870,000
Facility Closing [Member]
Note 12 - Restructuring Expense (Details) [Line Items]
Restructuring and Related Cost, Expected Cost	$ 200,000

XML

Note 2 - Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2015

Accounting Policies [Abstract]

Significant Accounting Policies [Text Block]

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expense during the reporting periods. The Company’s actual results could differ from these estimates.

Restricted Cash

As of June 30, 2015 and December 31, 2014, as required by the Company’s five-year term loan (as amended from time to time, the “Medley Term Loan”) with Medley Capital Corporation (“Medley”), the Company maintained a minimum restricted cash balance of $3.0 million to collateralize the Medley Term Loan. Changes in the restricted cash balance are reflected as a financing activity in the consolidated statement of cash flows.

Accounts Receivable

The Company records accounts receivable at the invoiced amount when its products are shipped to customers or when specific milestone billing requirements are completed. The Company’s accounts receivable balance is recorded net of allowances for amounts not expected to be collected from customers. This allowance for doubtful accounts is the Company’s best estimate of probable credit losses in the Company’s existing accounts receivable. Estimates used in determining the allowance for doubtful accounts are based on historical collection experience, age of receivables and known collectability issues. The Company writes off accounts receivable when it becomes apparent, based on age or customer circumstances, that such amounts will not be collected. The Company reviews its allowance for doubtful accounts on a quarterly basis. Recovery of bad debt amounts previously written off is recorded as a reduction of bad debt expense in the period the payment is collected. Generally, the Company does not require collateral for its accounts receivable and does not regularly charge interest on past due amounts. As of June 30, 2015 and December 31, 2014, the Company’s accounts receivable were reflected net of an allowance for doubtful accounts of $447,000 and $408,000, respectively.

As of June 30, 2015 and December 31, 2014, $5.2 million and $5.4 million, respectively, of eligible accounts receivable were pledged as collateral for the three-year asset based revolving credit facility (as amended from time to time, the “FCC ABL”) entered into on April 25, 2014 with FCC, LLC d/b/a First Capital (“First Capital”).

Revenue Recognition

The Company records revenue when its products are shipped and title passes to customers. When sales of products are subject to certain customer acceptance terms, revenue from such sales is recognized once those terms have been met. The Company also provides its customers with limited rights of return for non-conforming shipments or product warranty claims.

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (“ASU 2014‑09”). ASU 2014-09 seeks to clarify the principles for recognizing revenue and to develop a common revenue standard for GAAP and International Financial Reporting Standards. ASU 2014‑09 initially was effective for fiscal years, and interim periods within those years, beginning after December 15, 2016. However, at its July 9, 2015 meeting, the FASB agreed to defer by one year the mandatory effective date of this standard, but will also provide the option to adopt it as of the original effective date. The Company is currently evaluating the impact of adopting ASU 2014‑09, but the standard is not expected to have a significant effect on its consolidated financial statements.

Product Warranties

The Company generally provides a five-year limited warranty covering defective materials and workmanship of its products. Such warranty may require the Company to repair, replace or reimburse the purchaser for the purchase price of the product. The estimated costs related to warranties are accrued at the time products are sold based on various factors, including the Company’s stated warranty policies and practices, the historical frequency of claims and the cost to repair or replace its products under warranty. The warranty provision is included in accrued expenses on the condensed consolidated balance sheet. Changes in the warranty provision for the six months ended June 30, 2015 were as follows:

Warranty provision as of December 31, 2014	$	4,789,470
Additions to provision		925,361
Less warranty costs		(1,743,943	)
Warranty provision as of June 30, 2015	$	3,970,888

Fair Value Measurements

The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:

• Level 1 Inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.

• Level 2 Inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.

• Level 3 Inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.

Fair Value of Financial Instruments

Cash and cash equivalents, accounts receivable, accounts payable, amounts due under lines of credit and other short term borrowings, accrued expenses and the note payable are carried at amounts that approximate their fair value due to the short-term maturity of these instruments and/or variable, market driven interest rates.

The liabilities under derivative contracts, which represent warrants to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), were initially recorded at fair value and subsequently reflected at their fair value at the end of each reporting period. The fair value of the warrant issued to The Home Depot, Inc. (the “THD Warrant”) in January 2011, is determined using the Monte Carlo valuation method and will be adjusted at each reporting date until the underlying shares have been earned for each year. Such adjustments will be recorded as a reduction in the related revenue (sales incentive) from The Home Depot, Inc. ("The Home Depot"). Once a portion of the THD Warrant vests it is recorded at its fair value at the end of each subsequent reporting period.

Reclassification

Certain prior period amounts in the accompanying consolidated financial statements have been reclassified to conform to the current year presentation. These reclassifications had no effect on previously reported net loss or stockholders’ deficit.

XML

Note 10 - Earnings (Loss) Per Share (Details) - $ / shares shares in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Jan. 30, 2015
Note 10 - Earnings (Loss) Per Share (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	265.9	188.7	260.2	191.0
Series J Warrants [Member]
Note 10 - Earnings (Loss) Per Share (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$ 0.001		$ 0.001		$ 0.001

XML

Note 12 - Restructuring Expense (Tables)

6 Months Ended

Jun. 30, 2015

Restructuring and Related Activities [Abstract]

Restructuring and Related Costs [Table Text Block]

	For the Six Months Ended June 30,
	2015		2014
Broad based reduction of facilities and personnel (1)	$	297,770	$	91,568
Organization Optimization Initiative (2)		-		114,277
Total	$	297,770	$	205,845

Schedule of Restructuring Reserve by Type of Cost [Table Text Block]

	Workforce			Excess			Other
	Reduction			Facilities			Exit Costs			Total
Accrued liability as of December 31, 2014	$	959,240		$	353,269		$	138,840		$	1,451,349
Charges		297,770			-			-			297,770
Payments		(801,012	)		(77,207	)		(1,013	)		(879,232	)
Accrued liability as of June 30, 2015	$	455,998		$	276,062		$	137,827		$	869,887

XML

Note 10 - Earnings (Loss) Per Share (Tables)

6 Months Ended

Jun. 30, 2015

Note 10 - Earnings (Loss) Per Share (Tables) [Line Items]

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	For the Six Months Ended June 30,
	2015						2014
	Controlling Stockholders			Noncontrolling Stockholders			Controlling Stockholders			Noncontrolling Stockholders
Basic and diluted net income per share:
Net loss attributable to common stock	$	(12,012,096	)	$	(4,033,307	)	$	(41,848,973	)	$	(9,873,506	)
Deemed dividends due to the issuance of Pegasus Guaranty Warrantsas compensation for guaranty provided by controlling shareholders		-			-			570,574			(570,574	)
Deemed dividends related to the Series J Preferred Stock attributable to all shareholders		(11,462,973	)		(3,848,927	)		(24,542,113	)		(5,790,266	)
Undistributed net loss	$	(23,475,069	)	$	(7,882,234	)	$	(65,820,512	)	$	(16,234,346	)
Basic and diluted weighted average number of common shares outstanding		293,080,898			98,407,895			203,060,746			47,908,501
Basic and diluted net loss per common share	$	(0.08	)	$	(0.08	)	$	(0.32	)	$	(0.34	)

First Quarter [Member]

Note 10 - Earnings (Loss) Per Share (Tables) [Line Items]

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	For the Three Months Ended June 30,
	2015						2014
	Controlling Stockholders			Noncontrolling Stockholders			Controlling Stockholders			Noncontrolling Stockholders
Basic and diluted net income per share:
Net loss attributable to common stock	$	(1,834,659	)	$	(609,654	)	$	(9,299,729	)	$	(2,328,787	)
Deemed dividends related to the Series J Preferred Stock attributable to all shareholders		(10,238	)		(3,402	)		(106,973	)		(26,787	)
Undistributed net loss	$	(1,844,897	)	$	(613,056	)	$	(9,406,702	)	$	(2,355,574	)
Basic and diluted weighted average number of common shares outstanding		298,344,752			99,139,522			234,753,151			58,785,605
Basic and diluted net loss per common share	$	(0.01	)	$	(0.01	)	$	(0.04	)	$	(0.04	)

XML

Note 10 - Earnings (Loss) Per Share (Details) - Computation of Basic and Diluted Net Loss Per Share of Common Stock - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Controlling Shareholders [Member]
Basic and diluted net income per share:
Net loss attributable to common stock	$ (1,834,659)	$ (9,299,729)	$ (12,012,096)	$ (41,848,973)
Undistributed net loss	$ (1,844,897)	$ (9,406,702)	$ (23,475,069)	$ (65,820,512)
Basic and diluted weighted average number of common shares outstanding (in Shares)	298,344,752	234,753,151	293,080,898	203,060,746
Basic and diluted net loss per common share (in Dollars per share)	$ (0.01)	$ (0.04)	$ (0.08)	$ (0.32)
Noncontrolling Shareholders [Member]
Basic and diluted net income per share:
Net loss attributable to common stock	$ (609,654)	$ (2,328,787)	$ (4,033,307)	$ (9,873,506)
Undistributed net loss	$ (613,056)	$ (2,355,574)	$ (7,882,234)	$ (16,234,346)
Basic and diluted weighted average number of common shares outstanding (in Shares)	99,139,522	58,785,605	98,407,895	47,908,501
Basic and diluted net loss per common share (in Dollars per share)	$ (0.01)	$ (0.04)	$ (0.08)	$ (0.34)
Series J Preferred Stock [Member] | Controlling Shareholders [Member]
Basic and diluted net income per share:
Deemed dividends related to the Series J Preferred Stock attributable to all shareholders	$ (10,238)	$ (106,973)	$ (11,462,973)	$ (24,542,113)
Series J Preferred Stock [Member] | Noncontrolling Shareholders [Member]
Basic and diluted net income per share:
Deemed dividends related to the Series J Preferred Stock attributable to all shareholders	$ (3,402)	$ (26,787)	$ (3,848,927)	$ (5,790,266)

XML

Note 2 - Summary of Significant Accounting Policies (Details) - USD ($)	6 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Restricted Cash and Cash Equivalents, Current	$ 3,000,000
Allowance for Doubtful Accounts Receivable	$ 447,000	$ 408,000
Products Warranty Term	5 years
Common Stock, Par or Stated Value Per Share (in Dollars per share)	$ 0.001	$ 0.001
First Capital [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Debt Instrument, Collateral Amount	$ 5,200,000	$ 5,400,000
Medley Term Loan [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Debt Instrument, Term	5 years
Minimum [Member] | Medley Term Loan [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Restricted Cash and Cash Equivalents, Current	$ 3,000,000	$ 3,000,000

XML

Note 2 - Summary of Significant Accounting Policies (Details) - Summary of Warranty Provision	6 Months Ended
	Jun. 30, 2015 USD ($)
Summary of Warranty Provision [Abstract]
Warranty provision	$ 3,970,888
Additions to provision	925,361
Less warranty costs	$ (1,743,943)

XML

Note 1 - Description of Business and Basis of Presentation

6 Months Ended

Jun. 30, 2015

Disclosure Text Block [Abstract]

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

NOTE 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

Overview

Lighting Science Group Corporation (the “Company”) was incorporated in Delaware in 1988 and designs, develops, manufactures and markets general illumination products that use light emitting diodes (“LEDs”) as their exclusive light source. The Company’s product portfolio includes LED-based retrofit lamps (replacement bulbs) used in existing light fixtures as well as purpose built LED-based luminaires (light fixtures). The Company’s lamps and luminaires are used for many common indoor and outdoor residential, commercial, industrial and public infrastructure lighting applications. The Company assembles and manufactures products primarily through its contract manufacturers in Asia.

Basis of Financial Statement Presentation

The accompanying unaudited condensed consolidated financial statements are presented pursuant to the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) in accordance with the disclosure requirements for the quarterly report on Form 10-Q and therefore do not include all of the information and footnotes required by generally accepted accounting principles in the United States of America (“GAAP”) for complete financial statements. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments) necessary to fairly state the results for the interim periods presented. The condensed consolidated balance sheet as of December 31, 2014 is derived from the Company’s audited financial statements. Operating results for the three and six months ended June 30, 2015 are not necessarily indicative of the results of the Company that may be expected for the year ending December 31, 2015. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements as of and for the year ended December 31, 2014 and notes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on March 31, 2015.

The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in the accompanying condensed consolidated financial statements.

XML

Note 3 - Liquidity and Capital Resources (Details) - USD ($)		6 Months Ended
	Jan. 30, 2015	Jun. 30, 2015	Dec. 31, 2014	Jun. 30, 2014	Dec. 31, 2013
Note 3 - Liquidity and Capital Resources (Details) [Line Items]
Retained Earnings (Accumulated Deficit)		$ (816,373,976)	$ (800,328,573)
Stockholders' Equity Attributable to Parent		(512,293,550)	(487,056,183)
Cash and Cash Equivalents, at Carrying Value		346,572	1,609,297	$ 750,412	$ 11,195,412
Restricted Cash and Cash Equivalents, Current		$ 3,000,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)		251,104,819
Line of Credit, Current		$ 11,175,467	6,368,793
Preferred Stock, Redemption Amount		492,000,000
Debt, Long-term and Short-term, Combined Amount		$ 39,700,000
First Capital [Member]
Note 3 - Liquidity and Capital Resources (Details) [Line Items]
Debt Instrument, Term		3 years
Line of Credit Facility, Maximum Borrowing Capacity		$ 22,500,000
Line of Credit, Current		11,175,467	$ 6,368,793
Line of Credit Facility, Remaining Borrowing Capacity		2,000,000
Series J Preferred Stock [Member] | Holdings III [Member] | Series J Redeemable Convertible Preferred Stock [Member]
Note 3 - Liquidity and Capital Resources (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)	11,525
Share Price (in Dollars per share)	$ 1,000
Proceeds from Issuance of Redeemable Preferred Stock	$ 11,500,000
Convertible Preferred Stock, Shares Issued upon Conversion (in Shares)	1
Geveran Case [Member]
Note 3 - Liquidity and Capital Resources (Details) [Line Items]
Loss Contingency, Damages Sought, Value		$ 25,000,000
Series J Warrants [Member]
Note 3 - Liquidity and Capital Resources (Details) [Line Items]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in Shares)	2,650
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$ 0.001	$ 0.001
Medley Term Loan [Member]
Note 3 - Liquidity and Capital Resources (Details) [Line Items]
Debt Instrument, Term		5 years
Line of Credit Facility, Maximum Borrowing Capacity		$ 30,500,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)		5,000,000

XML

Note 8 - Fair Value Measurements (Details) - Reconciliation of Beginning and Ending Balances for Assets and Liabilities Accounted For at Fair Value on a Recurring Basis - Fair Value, Inputs, Level 3 [Member] - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Note 8 - Fair Value Measurements (Details) - Reconciliation of Beginning and Ending Balances for Assets and Liabilities Accounted For at Fair Value on a Recurring Basis [Line Items]
Beginning balance	$ (4,916,944)	$ (7,767,711)
Realized and unrealized gains (losses) included in net loss	(3,581,470)	(27,496,388)
Purchases, sales, issuances and settlements		(19,012,674)
Transfers in or out of Level 3		37,571,724
Ending balance	(8,498,414)	(16,705,049)
Pegasus Commitment [Member]
Note 8 - Fair Value Measurements (Details) - Reconciliation of Beginning and Ending Balances for Assets and Liabilities Accounted For at Fair Value on a Recurring Basis [Line Items]
Beginning balance	720,000	1,407,335
Realized and unrealized gains (losses) included in net loss	(456,000)	592,665
Ending balance	264,000	2,000,000
Riverwood Warrants [Member]
Note 8 - Fair Value Measurements (Details) - Reconciliation of Beginning and Ending Balances for Assets and Liabilities Accounted For at Fair Value on a Recurring Basis [Line Items]
Beginning balance	(2,352,027)	(5,002,664)
Realized and unrealized gains (losses) included in net loss	(1,005,943)	(1,691,565)
Ending balance	(3,357,970)	(6,694,229)
September 2012 Warrants [Member]
Note 8 - Fair Value Measurements (Details) - Reconciliation of Beginning and Ending Balances for Assets and Liabilities Accounted For at Fair Value on a Recurring Basis [Line Items]
Beginning balance	(720,000)	(1,407,335)
Realized and unrealized gains (losses) included in net loss	456,000	(592,665)
Ending balance	(264,000)	(2,000,000)
Pegasus Warrant [Member]
Note 8 - Fair Value Measurements (Details) - Reconciliation of Beginning and Ending Balances for Assets and Liabilities Accounted For at Fair Value on a Recurring Basis [Line Items]
Beginning balance	(1,300,000)	(2,765,047)
Realized and unrealized gains (losses) included in net loss	(556,000)	(934,953)
Ending balance	(1,856,000)	(3,700,000)
THD Warrant [Member]
Note 8 - Fair Value Measurements (Details) - Reconciliation of Beginning and Ending Balances for Assets and Liabilities Accounted For at Fair Value on a Recurring Basis [Line Items]
Beginning balance	(43,928)
Realized and unrealized gains (losses) included in net loss	(163,689)
Transfers in or out of Level 3		(74,576)
Ending balance	(207,617)	(74,576)
Medley Warrants [Member]
Note 8 - Fair Value Measurements (Details) - Reconciliation of Beginning and Ending Balances for Assets and Liabilities Accounted For at Fair Value on a Recurring Basis [Line Items]
Beginning balance	(577,065)
Realized and unrealized gains (losses) included in net loss	(912,121)	139,858
Purchases, sales, issuances and settlements		(3,170,361)
Ending balance	(1,489,186)	(3,030,503)
Pegasus Guaranty Warrants [Member]
Note 8 - Fair Value Measurements (Details) - Reconciliation of Beginning and Ending Balances for Assets and Liabilities Accounted For at Fair Value on a Recurring Basis [Line Items]
Beginning balance	(643,924)
Realized and unrealized gains (losses) included in net loss	(943,717)	130,833
Purchases, sales, issuances and settlements		(3,336,574)
Ending balance	$ (1,587,641)	(3,205,741)
Series J Warrants [Member]
Note 8 - Fair Value Measurements (Details) - Reconciliation of Beginning and Ending Balances for Assets and Liabilities Accounted For at Fair Value on a Recurring Basis [Line Items]
Realized and unrealized gains (losses) included in net loss		(25,140,561)
Purchases, sales, issuances and settlements		(12,505,739)
Transfers in or out of Level 3		$ 37,646,300

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 346,572	$ 1,609,297
Restricted cash	3,000,000	3,000,000
Accounts receivable, net	10,719,609	10,417,985
Inventories	20,046,254	22,726,162
Prepaid expenses	2,520,735	2,936,837
Other current assets	2,185,801	1,610,544
Total current assets	38,818,971	42,300,825
Property and equipment, net (includes accumulated depreciation of $11.3 million and $10.3 million as of June 30, 2015 and December 31, 2014, respectively)	1,733,073	2,650,115
Intangible assets, net	2,752,841	2,572,479
Pegasus Commitment	264,000	720,000
Debt issuance costs, less current portion	2,546,480	3,230,446
Other long-term assets	133,975	118,467
Total assets	46,249,340	51,592,332
Current liabilities:
Lines of credit	11,175,467	6,368,793
Current portion of long-term debt	69,061	58,574
Accounts payable	8,182,957	19,364,552
Provision for losses on non-cancelable purchase commitments	44,215	540,227
Accrued expenses	9,835,971	9,924,316
Total current liabilities	29,307,671	36,256,462
Note payable	28,516,029	27,813,061
Long-term debt, less current portion		35,272
Liabilities under derivative contracts	8,762,414	5,636,944
Total other liabilities	37,278,443	33,485,277
Total liabilities	66,586,114	69,741,739
Redeemable Convertible Preferred Stock	$ 491,956,776	$ 468,906,776
Commitments and contingencies
Stockholders' deficit:
Preferred stock, $.001 par value, authorized 25,000,000 shares, 113,609 shares of Series H, 62,365 shares of Series I and 70,000 shares of Series J issued and outstanding as of June 30, 2015 and 113,609 shares of Series H, 62,365 shares of Series I and 58,475 shares of Series J issued and outstanding as of December 31, 2014	$ 0	$ 0
Common stock, $.001 par value, authorized 975,000,000 shares, 214,489,993 and 212,452,636 shares issued as of June 30, 2015 and December 31, 2014, respectively	214,490	212,453
Additional paid-in capital	310,865,676	320,175,440
Accumulated deficit	(816,373,976)	(800,328,573)
Accumulated other comprehensive loss	(3,242,240)	(3,358,003)
Treasury stock, 2,505,000 shares as of June 30, 2015 and December 31, 2014 , at cost	(3,757,500)	(3,757,500)
Total stockholders’ deficit	(512,293,550)	(487,056,183)
Total liabilities and stockholders’ deficit	46,249,340	51,592,332
Series H Preferred Stock [Member]
Current liabilities:
Redeemable Convertible Preferred Stock	227,220,149	227,220,149
Series I Preferred Stock [Member]
Current liabilities:
Redeemable Convertible Preferred Stock	124,736,627	124,736,627
Series J Preferred Stock [Member]
Current liabilities:
Redeemable Convertible Preferred Stock	$ 140,000,000	$ 116,950,000

XML

Note 10 - Earnings (Loss) Per Share (Details) - Computation of Basic and Diluted Net Loss Per Share of Common Stock - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Controlling Shareholders [Member]
Basic and diluted net income per share:
Net loss attributable to common stock	$ (1,834,659)	$ (9,299,729)	$ (12,012,096)	$ (41,848,973)
Undistributed net loss	$ (1,844,897)	$ (9,406,702)	$ (23,475,069)	$ (65,820,512)
Basic and diluted weighted average number of common shares outstanding (in Shares)	298,344,752	234,753,151	293,080,898	203,060,746
Basic and diluted net loss per common share (in Dollars per share)	$ (0.01)	$ (0.04)	$ (0.08)	$ (0.32)
Noncontrolling Shareholders [Member]
Basic and diluted net income per share:
Net loss attributable to common stock	$ (609,654)	$ (2,328,787)	$ (4,033,307)	$ (9,873,506)
Undistributed net loss	$ (613,056)	$ (2,355,574)	$ (7,882,234)	$ (16,234,346)
Basic and diluted weighted average number of common shares outstanding (in Shares)	99,139,522	58,785,605	98,407,895	47,908,501
Basic and diluted net loss per common share (in Dollars per share)	$ (0.01)	$ (0.04)	$ (0.08)	$ (0.34)
Series J Preferred Stock [Member] | Controlling Shareholders [Member]
Basic and diluted net income per share:
Deemed dividends related to the Series J Preferred Stock attributable to all shareholders	$ (10,238)	$ (106,973)	$ (11,462,973)	$ (24,542,113)
Series J Preferred Stock [Member] | Noncontrolling Shareholders [Member]
Basic and diluted net income per share:
Deemed dividends related to the Series J Preferred Stock attributable to all shareholders	$ (3,402)	$ (26,787)	$ (3,848,927)	(5,790,266)
Pegasus Guaranty Warrants [Member] | Controlling Shareholders [Member]
Basic and diluted net income per share:
Deemed dividends due to the issuance of Pegasus Guaranty Warrantsas compensation for guaranty provided by controlling shareholders				570,574
Pegasus Guaranty Warrants [Member] | Noncontrolling Shareholders [Member]
Basic and diluted net income per share:
Deemed dividends due to the issuance of Pegasus Guaranty Warrantsas compensation for guaranty provided by controlling shareholders				$ (570,574)

XML

Condensed Consolidated Statement of Stockholders' Deficit (Unaudited) - 6 months ended Jun. 30, 2015 - USD ($)	Series J Warrants [Member] Additional Paid-in Capital [Member]	Series J Warrants [Member]	Series J Preferred Stock [Member] Additional Paid-in Capital [Member]	Series J Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Treasury Stock [Member]	Total
Balance at Dec. 31, 2014					$ 212,453	$ 320,175,440	$ (800,328,573)	$ (3,358,003)	$ (3,757,500)	$ (487,056,183)
Balance (in Shares) at Dec. 31, 2014					212,452,636
Issuance of restricted stock for directors' compensation					$ 2,034	127,431				129,465
Issuance of restricted stock for directors' compensation (in Shares)					2,033,905
Stock based compensation expense						2,235,720				2,235,720
Stock issued under equity compensation plans					$ 3	542				545
Stock issued under equity compensation plans (in Shares)					3,452
Issuance of Series J Warrants	$ 3,638,443	$ 3,638,443
Deemed dividends on Series J Redeemable Convertible Preferred Stock			$ (15,311,900)	$ (15,311,900)
Net loss							(16,045,403)			(16,045,403)
Foreign currency translation adjustment								115,763		115,763
Balance at Jun. 30, 2015					$ 214,490	$ 310,865,676	$ (816,373,976)	$ (3,242,240)	$ (3,757,500)	$ (512,293,550)
Balance (in Shares) at Jun. 30, 2015					214,489,993

XML

Note 5 - Intangible Assets (Details) - Summary of Intangible Assets - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Net Book Value	$ 2,752,841	$ 2,572,479
Technology and Intellectual Property [Member]
Finite-Lived Intangible Assets [Line Items]
Cost, Less Impairment Charges	3,017,232	2,796,580
Accumulated Amortization	(264,391)	(224,101)
Net Book Value	$ 2,752,841	$ 2,572,479
Minimum [Member] | Technology and Intellectual Property [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Remaining Useful Life	2 years 73 days	2 years 255 days
Maximum [Member] | Technology and Intellectual Property [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Remaining Useful Life	20 years	20 years

XML

Accounting Policies, by Policy (Policies)

6 Months Ended

Jun. 30, 2015

Accounting Policies [Abstract]

Basis of Accounting, Policy [Policy Text Block]

Basis of Financial Statement Presentation

The accompanying unaudited condensed consolidated financial statements are presented pursuant to the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) in accordance with the disclosure requirements for the quarterly report on Form 10-Q and therefore do not include all of the information and footnotes required by generally accepted accounting principles in the United States of America (“GAAP”) for complete financial statements. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments) necessary to fairly state the results for the interim periods presented. The condensed consolidated balance sheet as of December 31, 2014 is derived from the Company’s audited financial statements. Operating results for the three and six months ended June 30, 2015 are not necessarily indicative of the results of the Company that may be expected for the year ending December 31, 2015. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements as of and for the year ended December 31, 2014 and notes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on March 31, 2015.

The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in the accompanying condensed consolidated financial statements.

Use of Estimates, Policy [Policy Text Block]

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expense during the reporting periods. The Company’s actual results could differ from these estimates.

Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]

Restricted Cash

As of June 30, 2015 and December 31, 2014, as required by the Company’s five-year term loan (as amended from time to time, the “Medley Term Loan”) with Medley Capital Corporation (“Medley”), the Company maintained a minimum restricted cash balance of $3.0 million to collateralize the Medley Term Loan. Changes in the restricted cash balance are reflected as a financing activity in the consolidated statement of cash flows.

Trade and Other Accounts Receivable, Policy [Policy Text Block]

Accounts Receivable

The Company records accounts receivable at the invoiced amount when its products are shipped to customers or when specific milestone billing requirements are completed. The Company’s accounts receivable balance is recorded net of allowances for amounts not expected to be collected from customers. This allowance for doubtful accounts is the Company’s best estimate of probable credit losses in the Company’s existing accounts receivable. Estimates used in determining the allowance for doubtful accounts are based on historical collection experience, age of receivables and known collectability issues. The Company writes off accounts receivable when it becomes apparent, based on age or customer circumstances, that such amounts will not be collected. The Company reviews its allowance for doubtful accounts on a quarterly basis. Recovery of bad debt amounts previously written off is recorded as a reduction of bad debt expense in the period the payment is collected. Generally, the Company does not require collateral for its accounts receivable and does not regularly charge interest on past due amounts. As of June 30, 2015 and December 31, 2014, the Company’s accounts receivable were reflected net of an allowance for doubtful accounts of $447,000 and $408,000, respectively.

As of June 30, 2015 and December 31, 2014, $5.2 million and $5.4 million, respectively, of eligible accounts receivable were pledged as collateral for the three-year asset based revolving credit facility (as amended from time to time, the “FCC ABL”) entered into on April 25, 2014 with FCC, LLC d/b/a First Capital (“First Capital”).

Revenue Recognition, Policy [Policy Text Block]

Revenue Recognition

The Company records revenue when its products are shipped and title passes to customers. When sales of products are subject to certain customer acceptance terms, revenue from such sales is recognized once those terms have been met. The Company also provides its customers with limited rights of return for non-conforming shipments or product warranty claims.

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (“ASU 2014‑09”). ASU 2014-09 seeks to clarify the principles for recognizing revenue and to develop a common revenue standard for GAAP and International Financial Reporting Standards. ASU 2014‑09 initially was effective for fiscal years, and interim periods within those years, beginning after December 15, 2016. However, at its July 9, 2015 meeting, the FASB agreed to defer by one year the mandatory effective date of this standard, but will also provide the option to adopt it as of the original effective date. The Company is currently evaluating the impact of adopting ASU 2014‑09, but the standard is not expected to have a significant effect on its consolidated financial statements.

Standard Product Warranty, Policy [Policy Text Block]

Product Warranties

The Company generally provides a five-year limited warranty covering defective materials and workmanship of its products. Such warranty may require the Company to repair, replace or reimburse the purchaser for the purchase price of the product. The estimated costs related to warranties are accrued at the time products are sold based on various factors, including the Company’s stated warranty policies and practices, the historical frequency of claims and the cost to repair or replace its products under warranty. The warranty provision is included in accrued expenses on the condensed consolidated balance sheet. Changes in the warranty provision for the six months ended June 30, 2015 were as follows:

Warranty provision as of December 31, 2014	$	4,789,470
Additions to provision		925,361
Less warranty costs		(1,743,943	)
Warranty provision as of June 30, 2015	$	3,970,888

Fair Value of Financial Instruments, Policy [Policy Text Block]

Fair Value Measurements

The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:

• Level 1 Inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.

• Level 2 Inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.

• Level 3 Inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.

Fair Value of Financial Instruments

Cash and cash equivalents, accounts receivable, accounts payable, amounts due under lines of credit and other short term borrowings, accrued expenses and the note payable are carried at amounts that approximate their fair value due to the short-term maturity of these instruments and/or variable, market driven interest rates.

The liabilities under derivative contracts, which represent warrants to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), were initially recorded at fair value and subsequently reflected at their fair value at the end of each reporting period. The fair value of the warrant issued to The Home Depot, Inc. (the “THD Warrant”) in January 2011, is determined using the Monte Carlo valuation method and will be adjusted at each reporting date until the underlying shares have been earned for each year. Such adjustments will be recorded as a reduction in the related revenue (sales incentive) from The Home Depot, Inc. ("The Home Depot"). Once a portion of the THD Warrant vests it is recorded at its fair value at the end of each subsequent reporting period

Reclassification, Policy [Policy Text Block]

Reclassification

Certain prior period amounts in the accompanying consolidated financial statements have been reclassified to conform to the current year presentation. These reclassifications had no effect on previously reported net loss or stockholders’ deficit.

XML

Note 6 - Debt Issuance Costs (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Note 6 - Debt Issuance Costs (Details) [Line Items]
Amortization of Financing Costs	$ 400,000	$ 819,000	$ 733,452	$ 1,006,589
Other Current Assets [Member]
Note 6 - Debt Issuance Costs (Details) [Line Items]
Deferred Finance Costs, Current, Net	$ 1,600,000		1,600,000
First Capital and Medley [Member]
Note 6 - Debt Issuance Costs (Details) [Line Items]
Debt Issuance Cost			6,000,000
Pegasus Guaranty [Member]
Note 6 - Debt Issuance Costs (Details) [Line Items]
Debt Issuance Cost			$ 2,800,000

XML

Note 5 - Intangible Assets (Tables)

6 Months Ended

Jun. 30, 2015

Disclosure Text Block [Abstract]

Schedule of Finite-Lived Intangible Assets [Table Text Block]

	Cost, Less Impairment Charges		Accumulated Amortization			Net Book Value		Estimated Remaining Useful Life (years)
June 30, 2015:
Technology and intellectual property	$	3,017,232	$	(264,391	)	$	2,752,841	2.2 to 20.0
December 31, 2014:
Technology and intellectual property	$	2,796,580	$	(224,101	)	$	2,572,479	2.7 to 20.0

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Cash flows from operating activities:
Net loss	$ (16,045,403)	$ (51,722,479)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	994,143	2,076,323
Issuance of restricted stock for directors' compensation	129,465	199,368
Stock based compensation expense	2,235,720	2,218,544
Non-cash sales incentive	75,977	61,521
Allowance for doubtful accounts receivable	35,725	25,758
Write-down of inventory	485,102	1,094,049
Provision for losses on non-cancelable purchase commitments	(496,012)	(219,791)
Increase in fair value of derivative contracts	3,505,493	27,496,388
Amortization of debt issuance costs	733,452	1,006,589
Medley discount accretion	389,536	279,167
Interest accrued on Medley Term Loan	313,432	224,308
(Gain) loss on disposal of assets	(500)	50,199
Changes in operating assets and liabilities:
Accounts receivable	(313,140)	1,199,862
Inventories	2,194,806	(6,100,128)
Prepaid expenses	416,266	(739,662)
Other current and long-term assets	(301,502)	334,166
Accounts payable	(11,169,225)	2,153
Accrued expenses and other liabilities	(70,796)	(601,839)
Net cash used in operating activities	(16,887,461)	(23,115,504)
Cash flows from investing activities:
Purchases of property and equipment	(36,806)	(262,249)
Capitalized patents	(220,652)	(461,404)
Proceeds from sale of property and equipment	500	375,100
Net cash used in investing activities	(256,958)	(348,553)
Cash flows from financing activities:
Net proceeds (payments) from draws on lines of credit and other short-term borrowings	4,806,674	(32,718,274)
Proceeds from long-term borrowings		29,775,000
Payment of short and long-term debt	(24,785)	(2,667)
Debt issuance costs	(338,749)	(3,210,206)
Decrease in restricted cash related to line of credit		2,000,000
Proceeds from issuance of common stock under equity compensation plans	545	3,669
Fees incurred on issuance of preferred stock	(148,457)	(485,400)
Net cash provided by financing activities	15,820,228	12,837,122
Effect of exchange rate changes on cash	61,466	181,935
Net decrease in cash	(1,262,725)	(10,445,000)
Cash and cash equivalents balance at beginning of period	1,609,297	11,195,412
Cash and cash equivalents balance at end of period	346,572	750,412
Supplemental disclosures:
Interest paid during the period	2,597,495	2,562,656
Series J Preferred Stock [Member]
Cash flows from financing activities:
Proceeds from issuance of Series J Redeemable Convertible Preferred Securities	11,525,000	17,475,000
Non-cash investing and financing activities:
Deemed dividends	$ (15,311,900)	(30,332,379)
Series J Warrants [Member]
Non-cash investing and financing activities:
Reclass of Series J Warrants from liabilities to equity		37,646,300
THD Warrant [Member]
Non-cash investing and financing activities:
Reclass of THD Warrant from equity to liabilities		(74,576)
Pegasus Guaranty Warrants [Member]
Non-cash investing and financing activities:
Deemed dividends		(570,574)
Fair value of Pegasus Guaranty included in debt issuance costs		$ (2,766,000)

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($) $ in Millions	Jun. 30, 2015	Dec. 31, 2014
Accumulated Depreciation (in Dollars)	$ 11.3	$ 10.3
Redeemable Convertible Preferred Stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Redeemable Convertible Preferred Stock, authorized shares	25,000,000	25,000,000
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, authorized shares	975,000,000	975,000,000
Common stock, shares issued	214,489,993	212,452,636
Treasury stock, shares	2,505,000	2,505,000
Series H Preferred Stock [Member]
Redeemable Convertible Preferred Stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Redeemable Convertible Preferred Stock, authorized shares	135,000	135,000
Redeemable Convertible Preferred Stock, shares issued	113,609	113,609
Redeemable Convertible Preferred Stock, shares outstanding	113,609	113,609
Series I Preferred Stock [Member]
Redeemable Convertible Preferred Stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Redeemable Convertible Preferred Stock, authorized shares	90,000	90,000
Redeemable Convertible Preferred Stock, shares issued	62,365	62,365
Redeemable Convertible Preferred Stock, shares outstanding	62,365	62,365
Series J Preferred Stock [Member]
Redeemable Convertible Preferred Stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Redeemable Convertible Preferred Stock, authorized shares	70,100	70,000
Redeemable Convertible Preferred Stock, shares issued	70,000	58,475
Redeemable Convertible Preferred Stock, shares outstanding	70,000	58,475

XML

Note 10 - Earnings (Loss) Per Share

6 Months Ended

Jun. 30, 2015

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

NOTE 10: EARNINGS (LOSS) PER SHARE

In 2012, the Company determined that two classes of Common Stock had been established for financial reporting purposes only, with Common Stock attributable to controlling stockholders representing shares beneficially owned and controlled by Pegasus and the Common Stock attributable to noncontrolling stockholders representing the minority interest stockholders. For the three and six months ended June 30, 2015 and 2014, the Company computed net loss per share of noncontrolling stockholders and controlling stockholders of Common Stock using the two-class method. Net loss from operations is initially allocated based on the underlying common shares held by controlling and noncontrolling stockholders. The allocation of the net losses attributable to the Common Stock attributable to controlling stockholders is then reduced by the amount of the deemed dividend related to the warrants issued to the Pegasus Guarantors, while the allocation of net losses attributable to the Common Stock attributable to noncontrolling stockholders is increased by the amount of the deemed dividend related to the warrants issued to the Pegasus Guarantors

The following table sets forth the computation of basic and diluted net loss per share of Common Stock:

	For the Three Months Ended June 30,
	2015						2014
	Controlling Stockholders			Noncontrolling Stockholders			Controlling Stockholders			Noncontrolling Stockholders
Basic and diluted net income per share:
Net loss attributable to common stock	$	(1,834,659	)	$	(609,654	)	$	(9,299,729	)	$	(2,328,787	)
Deemed dividends related to the Series J Preferred Stock attributable to all shareholders		(10,238	)		(3,402	)		(106,973	)		(26,787	)
Undistributed net loss	$	(1,844,897	)	$	(613,056	)	$	(9,406,702	)	$	(2,355,574	)
Basic and diluted weighted average number of common shares outstanding		298,344,752			99,139,522			234,753,151			58,785,605
Basic and diluted net loss per common share	$	(0.01	)	$	(0.01	)	$	(0.04	)	$	(0.04	)

	For the Six Months Ended June 30,
	2015						2014
	Controlling Stockholders			Noncontrolling Stockholders			Controlling Stockholders			Noncontrolling Stockholders
Basic and diluted net income per share:
Net loss attributable to common stock	$	(12,012,096	)	$	(4,033,307	)	$	(41,848,973	)	$	(9,873,506	)
Deemed dividends due to the issuance of Pegasus Guaranty Warrantsas compensation for guaranty provided by controlling shareholders		-			-			570,574			(570,574	)
Deemed dividends related to the Series J Preferred Stock attributable to all shareholders		(11,462,973	)		(3,848,927	)		(24,542,113	)		(5,790,266	)
Undistributed net loss	$	(23,475,069	)	$	(7,882,234	)	$	(65,820,512	)	$	(16,234,346	)
Basic and diluted weighted average number of common shares outstanding		293,080,898			98,407,895			203,060,746			47,908,501
Basic and diluted net loss per common share	$	(0.08	)	$	(0.08	)	$	(0.32	)	$	(0.34	)

Basic earnings per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding for the applicable period. The Series J Warrants have an exercise price of $0.001 per share of Common Stock, and are included in the weighted average number of shares of Common Stock outstanding as there are no conditions that must be satisfied before such warrant may be exercised into the shares of Common Stock underlying such warrants. Diluted earnings per share is computed in the same manner as basic earnings per share except the number of shares is increased to assume exercise of potentially dilutive stock options, unvested restricted stock and contingently issuable shares using the treasury stock method and convertible preferred shares using the if-converted method, unless the effect of such increases would be anti-dilutive. The Company had 265.9 million and 188.7 million common stock equivalents for the three months ended June 30, 2015 and 2014, respectively, and 260.2 million and 191.0 million common stock equivalents for the six months ended June 30, 2015 and 2014, respectively, which were not included in the diluted net loss per common share as the common stock equivalents were anti-dilutive, as a result of being in a net loss position.

XML

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2015	Aug. 07, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	LIGHTING SCIENCE GROUP CORP
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		211,886,165
Amendment Flag	false
Entity Central Index Key	0000866970
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Jun. 30, 2015
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q2

XML

Note 11 - Related Party Transactions

6 Months Ended

Jun. 30, 2015

Related Party Transactions [Abstract]

Related Party Transactions Disclosure [Text Block]

NOTE 11: RELATED PARTY TRANSACTIONS 

Pegasus Capital is an affiliate of Pegasus IV and LSGC Holdings, which are the Company’s largest stockholders and beneficially owned approximately 88.6% of the Common Stock as of June 30, 2015.

On January 30, 2015, the Company issued an additional 11,525 units of Series J Securities, at a purchase price of $1,000 per Series J Security for aggregate proceeds of $11.5 million. The Series J Securities were issued pursuant to a subscription agreement between the Company and Holdings III, an affiliate of Pegasus Capital.

XML

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Revenue	$ 23,270,363	$ 19,827,864	$ 42,641,908	$ 45,753,705
Cost of goods sold (exclusive of depreciation shown below)	19,853,828	18,826,446	36,295,125	42,061,792
Gross profit	3,416,535	1,001,418	6,346,783	3,691,913
Operating expense:
Selling, distribution and administrative (includes related party expenses of $0 and $261,000 for the three months ended June 30, 2015 and 2014, respectively)	6,896,060	9,981,850	11,991,641	19,175,795
Research and development	1,052,997	1,534,582	2,234,310	3,078,606
Restructuring expense	214,066	793	297,770	205,845
Depreciation and amortization	488,071	1,000,313	994,143	2,076,323
Total operating expenses	8,651,194	12,517,538	15,517,864	24,536,569
Loss from operations	(5,234,659)	(11,516,120)	(9,171,081)	(20,844,656)
Other income (expense):
Interest income	1,163	225	1,163	636
Interest expense	(1,590,638)	(2,002,561)	(2,991,531)	(3,284,319)
Related party interest expense	(138,300)	(138,300)	(338,067)	(199,767)
Decrease in fair value of liabilities under derivative contracts	4,595,279	1,983,150	(3,505,493)	(27,496,388)
Other (expense) income, net	(77,158)	45,090	(40,394)	102,015
Total other income (expense)	2,790,346	(112,396)	(6,874,322)	(30,877,823)
Net loss	(2,444,313)	(11,628,516)	(16,045,403)	(51,722,479)
Foreign currency translation gain (loss)	70,372	(21,899)	115,763	150,705
Comprehensive loss	$ (2,373,941)	$ (11,650,415)	$ (15,929,640)	$ (51,571,774)
Parent [Member]
Other income (expense):
Basic and diluted net loss per weighted average common share (in Dollars per share)	$ (0.01)	$ (0.04)	$ (0.08)	$ (0.32)
Basic and diluted weighted average number of common shares outstanding (in Shares)	298,344,752	234,753,151	293,080,898	203,060,746
Noncontrolling Interest [Member]
Other income (expense):
Basic and diluted net loss per weighted average common share (in Dollars per share)	$ (0.01)	$ (0.04)	$ (0.08)	$ (0.34)
Basic and diluted weighted average number of common shares outstanding (in Shares)	99,139,522	58,785,605	98,407,895	47,908,501

XML

Note 5 - Intangible Assets

6 Months Ended

Jun. 30, 2015

Disclosure Text Block [Abstract]

Intangible Assets Disclosure [Text Block]

NOTE 5. INTANGIBLE ASSETS

Intangible assets that have finite lives are amortized over their useful lives. The Company’s intangible assets as of June 30, 2015 and December 31, 2014 are detailed below:

	Cost, Less Impairment Charges		Accumulated Amortization			Net Book Value		Estimated Remaining Useful Life (years)
June 30, 2015:
Technology and intellectual property	$	3,017,232	$	(264,391	)	$	2,752,841	2.2 to 20.0
December 31, 2014:
Technology and intellectual property	$	2,796,580	$	(224,101	)	$	2,572,479	2.7 to 20.0

Total intangible asset amortization expense was $21,000 and $16,000 for the three months ended June 30, 2015 and 2014, respectively. Total intangible asset amortization expense was $40,000 and $29,000 for the six months ended June 30, 2015 and 2014, respectively.

XML

Note 4 - Detail of Certain Balance Sheet Accounts

6 Months Ended

Jun. 30, 2015

Disclosure Text Block Supplement [Abstract]

Supplemental Balance Sheet Disclosures [Text Block]

NOTE 4. DETAIL OF CERTAIN BALANCE SHEET ACCOUNTS

Inventories

Inventories consisted primarily of finished goods as of June 30, 2015 and December 31, 2014. As of June 30, 2015 and December 31, 2014, inventories were stated net of inventory write downs of $5.1 million and $7.9 million, respectively. The Company considered a number of factors in estimating the required inventory write downs, including (i) the focus of the business on the next generation of the Company’s products, which utilize lower cost technologies, (ii) the strategic focus on core products to meet the demands of key customers and (iii) the expected demand for the Company’s current generation of products, which is approaching the end of its lifecycle upon the introduction of the next generation of products.

Property and Equipment, Net

Depreciation related to property and equipment was $467,000 and $985,000 for the three months ended June 30, 2015 and 2014, respectively. Depreciation related to property and equipment was $954,000 and $2.1 million for the six months ended June 30, 2015 and 2014, respectively.

XML

Note 2 - Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2015

Accounting Policies [Abstract]

Schedule of Product Warranty Liability [Table Text Block]

Warranty provision as of December 31, 2014	$	4,789,470
Additions to provision		925,361
Less warranty costs		(1,743,943	)
Warranty provision as of June 30, 2015	$	3,970,888

XML

Note 12 - Restructuring Expense

6 Months Ended

Jun. 30, 2015

Restructuring and Related Activities [Abstract]

Restructuring and Related Activities Disclosure [Text Block]

NOTE 12. RESTRUCTURING EXPENSE

The following table summarizes the Company’s restructuring expense and related charges for the periods indicated:

	For the Six Months Ended June 30,
	2015		2014
Broad based reduction of facilities and personnel (1)	$	297,770	$	91,568
Organization Optimization Initiative (2)		-		114,277
Total	$	297,770	$	205,845

(1) These charges relate to a significant cost reduction plan initiated during the fourth quarter of 2013 that includes moving the majority of the Company’s manufacturing to its contract manufacturers in Asia, related workforce reductions in Satellite Beach, Florida and cost reductions in our foreign subsidiaries. The Company estimates it will incur $200,000 in additional expenses throughout this cost reduction plan, primarily related to additional headcount reductions. These additional costs are expected to be incurred during 2015.

(2) In September 2011, the Company began implementing a restructuring plan designed to further increase efficiencies across the organization and lower the overall cost structure. In 2012, the Company extended the restructuring plan to further increase efficiencies across the organization and lower its overall cost structure. The plan included a significant reduction in full time headcount and the closing of the Company’s offices in the United Kingdom and Australia. For the six months ended June 30, 2014, these expenses related to the final liquidation of the Australian entity.

As of June 30, 2015, the accrued liability associated with the restructuring and other related charges consisted of the following:

	Workforce			Excess			Other
	Reduction			Facilities			Exit Costs			Total
Accrued liability as of December 31, 2014	$	959,240		$	353,269		$	138,840		$	1,451,349
Charges		297,770			-			-			297,770
Payments		(801,012	)		(77,207	)		(1,013	)		(879,232	)
Accrued liability as of June 30, 2015	$	455,998		$	276,062		$	137,827		$	869,887

The remaining accrual of $870,000 as of June 30, 2015 is expected to be paid during the year ending December 31, 2015.

The restructuring and other related charges are included in the line item restructuring expense in the condensed consolidated statement of operations and comprehensive loss.

XML

Note 8 - Fair Value Measurements

6 Months Ended

Jun. 30, 2015

Fair Value Disclosures [Abstract]

Fair Value Disclosures [Text Block]

NOTE 8. FAIR VALUE MEASUREMENTS

The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of June 30, 2015, according to the valuation techniques the Company used to determine their fair values:

	Fair Value Measurement as of June 30, 2015
	Quoted Price in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
	Level 1		Level 2		Level 3
Assets (Recurring):
Pegasus Commitment	$	-	$	-	$	264,000
Liabilities (Recurring):
Riverwood Warrants	$	-	$	-	$	3,357,970
September 2012 Warrants		-		-		264,000
Pegasus Warrant		-		-		1,856,000
THD Warrant		-		-		207,617
Medley Warrants		-		-		1,489,186
Pegasus Guaranty Warrants		-		-		1,587,641
	$	-	$	-	$	8,762,414

The following table is a reconciliation of the beginning and ending balances for assets and liabilities that were accounted for at fair value on a recurring basis using Level 3 inputs, as defined above, for the six months ended June 30, 2015:

				Realized and unrealized			Purchases, sales,		Transfers in
	Balance			gains (losses) included			issuances and		or out of		Balance
	December 31, 2014			in net loss			settlements		Level 3		June 30, 2015
Pegasus Commitment	$	720,000		$	(456,000	)	$	-	$	-	$	264,000
Riverwood Warrants		(2,352,027	)		(1,005,943	)		-		-		(3,357,970	)
September 2012 Warrants		(720,000	)		456,000			-		-		(264,000	)
Pegasus Warrant		(1,300,000	)		(556,000	)		-		-		(1,856,000	)
THD Warrant		(43,928	)		(163,689	)		-		-		(207,617	)
Medley Warrants		(577,065	)		(912,121	)		-		-		(1,489,186	)
Pegasus Guaranty Warrants		(643,924	)		(943,717	)		-		-		(1,587,641	)
Total	$	(4,916,944	)	$	(3,581,470	)	$	-	$	-	$	(8,498,414	)

The following table is a reconciliation of the beginning and ending balances for assets and liabilities that were accounted for at fair value on a recurring basis using Level 3 inputs, as defined above, for the six months ended June 30, 2014:

				Realized and unrealized			Purchases, sales,			Transfers in
	Balance			gains (losses) included			issuances and			or out of			Balance
	December 31, 2013			in net loss			settlements			Level 3			June 30, 2014
Pegasus Commitment	$	1,407,335		$	592,665		$	-		$	-		$	2,000,000
Riverwood Warrants		(5,002,664	)		(1,691,565	)		-			-			(6,694,229	)
September 2012 Warrants		(1,407,335	)		(592,665	)		-			-			(2,000,000	)
Pegasus Warrant		(2,765,047	)		(934,953	)		-			-			(3,700,000	)
THD Warrant		-			-			-			(74,576	)		(74,576	)
Series J Warrants		-			(25,140,561	)		(12,505,739	)		37,646,300			-
Medley Warrants		-			139,858			(3,170,361	)		-			(3,030,503	)
Pegasus Guaranty Warrants		-			130,833			(3,336,574	)		-			(3,205,741	)
Total	$	(7,767,711	)	$	(27,496,388	)	$	(19,012,674	)	$	37,571,724		$	(16,705,049	)

XML

Note 6 - Debt Issuance Costs

6 Months Ended

Jun. 30, 2015

Debt Issuance Costs [Abstract]

Debt Issuance Costs [Text Block]

NOTE 6. DEBT ISSUANCE COSTS

The Company capitalizes its costs related to the issuance of long-term debt and amortizes these costs using the effective interest rate method over the life of the loan. Amortization of debt issuance costs and the accelerated write-off of debt issuance costs in connection with refinancing activities are recorded as a component of interest expense. As of June 30, 2015, the current portion of the debt issuance costs was $1.6 million and was included in other current assets. In connection with the FCC ABL and the Medley Term Loan, $6.0 million of debt issuance costs were capitalized, including $2.8 million related to the fair value of the guaranty of the Company’s obligations under the Medley Loan Agreement in favor of Medley (the “Pegasus Guaranty”) provided by Pegasus Capital Partners IV, L.P. and Pegasus Capital Partners V, L.P. (collectively, the “Pegasus Guarantors”). The Company amortized $400,000 and $819,000 of debt issuance costs for the three months ended June 30, 2015 and 2014, respectively. The Company amortized $733,000 and $1.0 million of debt issuance costs for the six months ended June 30, 2015 and 2014, respectively.

XML

Note 7 - Lines of Credit and Note Payable

6 Months Ended

Jun. 30, 2015

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

NOTE 7. LINES OF CREDIT AND NOTE PAYABLE

	Balance Outstanding as of
Facility	June 30, 2015		December 31, 2014
FCC ABL, revolving line of credit	$	11,175,467	$	6,368,793
Medley Term Loan		28,516,029		27,813,061
	$	39,691,496	$	34,181,854

FCC ABL

On April 25, 2014, the Company, entered into the FCC ABL, which provides the Company with a maximum borrowing capacity of $22.5 million, which capacity is based on a formula of eligible accounts receivable and inventory. As of June 30, 2015, the Company had additional borrowing capacity of $2.0 million. As of June 30 2015, eligible collateral included $5.2 million of accounts receivable and $8.5 million of inventory. Borrowings under the FCC ABL bear interest at a floating rate equal to one-month LIBOR plus 4.0% per annum. As of June 30, 2015, the interest rate on the FCC ABL was 4.18%.

On January 30, 2015, the Company entered into an amendment to the FCC ABL, which provided additional notification and consent requirements as well as updates to certain disclosure schedules to the FCC ABL agreement. In connection with this amendment First Capital also agreed to amend the calculation of EBITDA for purposes of determining compliance with the fixed charge coverage ratio covenant for each of the six-month period ending March 31, 2015, the nine-month period ending June 30, 2015, the twelve-month period ending September 30, 2015 and the twelve-month period ending December 31, 2015.

Medley Term Loan

On February 19, 2014, the Company entered into the Medley Term Loan, which provided the Company with a $30.5 million term loan facility. The Medley Term Loan bears interest at a floating rate equal to three-month LIBOR plus 12% per annum, and as of June 30, 2015, the interest rate on the Medley Term Loan was 12.28%. Additionally, $3.0 million of the Medley Term Loan was funded directly into a deposit account to which Medley has exclusive access, to further secure the loan. The outstanding principal balance and all accrued and unpaid interest on the Medley Term Loan are due and payable on February 19, 2019. The Company recognized $195,000 of interest expense for the accretion of the discounts to the balance of the Medley Term Loan related to commitment fees and the Medley Warrants for both the three months ended June 30, 2015 and 2014, and $158,000 and $155,000 of accrued interest for the three months ended June 30, 2015 and 2014, respectively. The Company recognized $390,000 of interest expense for the accretion of the discounts to the balance of the Medley Term Loan related to commitment fees and the Medley Warrants and $313,000 of accrued interest for the six months ended June 30, 2015, and $279,000 of interest expense for the accretion of the discounts to the balance of the Medley Term Loan related to the commitment fees and the Medley Warrants and $224,000 of accrued interest for the period from February 19, 2014 (date of issuance) to June 30, 2014.

On January 30, 2015, the Company entered into an amendment to the Medley Term Loan, which, among other things, provided additional notification and consent requirements, amends the minimum EBITDA covenant levels with respect to each of the six-month period ending March 31, 2015, the nine-month period ending June 30, 2015, the twelve-month period ending September 30, 2015 and the twelve-month period ending December 31, 2015 and amended the definition of fixed charge coverage ratio.

XML

Note 9 - Stockholders' Equity

6 Months Ended

Jun. 30, 2015

Stockholders' Equity Note [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

NOTE 9. STOCKHOLDERS' EQUITY

For the three months ended June 30, 2015 and 2014, the Company recorded expense of $118,000 and $126,000, respectively, related to restricted stock awards to the Company’s directors. For the six months ended June 30, 2015 and 2014, the Company recorded expense of $129,000 and $199,000, respectively, related to restricted stock awards to the Company’s directors.

On June 12, 2014, the Board approved the formation of a Scientific Advisory Board (the “SAB”) and issued restricted stock awards to each of the five members of the SAB as part of their compensation package. For the three and six months ended June 30, 2015, the Company recorded expense of $30,000 and $63,000, respectively, related to restricted stock awards to the Company’s SAB.

Warrants for the Purchase of Common Stock

As of June 30, 2015, the following warrants for the purchase of Common Stock were outstanding:

Warrant Holder	Reason for Issuance	Number of Common Shares		Exercise Price		Expiration Date
Investors in rights offering	Series D Warrants		1,072,617	$	2.95 to $2.96	March 3, 2022 through April 19, 2022
The Home Depot	Purchasing agreement		7,609,183	$	1.05	December 31, 2015 through 2018
RW LSG Management Holdings LLC	Riverwood Warrants		12,664,760	Variable		May 25, 2022
Certain other investors	Riverwood Warrants		5,427,751	Variable		May 25, 2022
Cleantech Europe II (A) LP	September 2012 Warrants		3,406,041	$	0.72	September 25, 2022
Cleantech Europe II (B) LP	September 2012 Warrants		593,959	$	0.72	September 25, 2022
Portman Limited	September 2012 Warrants		4,000,000	$	0.72	September 25, 2022
Aquillian Investments LLC	Private Placement Series H		830,508	$	1.18	September 25, 2017
Pegasus	Pegasus Warrant		10,000,000	Variable		May 25, 2022
Investors in Series J Follow-On Offering	Series J Warrants		185,500,000	$	0.001	January 3, 2019 through January 30, 2020
Medley	Medley Warrants		10,000,000	$	0.95	February 19, 2024
Pegasus	Pegasus Guaranty Warrants		10,000,000	$	0.50	February 19, 2024
			251,104,819

XML

Note 5 - Intangible Assets (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Disclosure Text Block [Abstract]
Amortization of Intangible Assets	$ 21,000	$ 16,000	$ 40,000	$ 29,000

XML

Note 14 - Commitments and Contingencies (Details) $ in Millions	6 Months Ended
	Jun. 30, 2015 USD ($)
Geveran Case [Member]
Note 14 - Commitments and Contingencies (Details) [Line Items]
Loss Contingency, Damages Sought, Value	$ 25.0

XML

Note 14 - Commitments and Contingencies

6 Months Ended

Jun. 30, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

NOTE 14. COMMITMENTS AND CONTINGENCIES 

The Company is subject to the possibility of loss contingencies arising in its business. Such contingencies are accounted for in accordance with ASC Topic 450, “Contingencies.” In determining loss contingencies, the Company considers the possibility of a loss and the ability to reasonably estimate the amount of such loss or liability. An estimated loss is recorded when it is considered probable that a liability has been incurred and when the amount of loss can be reasonably estimated.

Legal Proceedings

In the ordinary course of business, the Company is routinely a party to various pending and threatened legal claims and proceedings. While the ultimate outcome of these matters cannot be predicted with certainty, based on information currently available and advice of counsel, and taking into account available insurance coverage, except as noted below, the Company does not believe that the outcome of any of these claims will have a material adverse effect on its business, financial condition or results of operations. However, the results of legal proceedings cannot be predicted with certainty, and in the event of unexpected future developments the ultimate resolution of one or more of these matters could be unfavorable. Should the Company fail to prevail in any of these legal matters or should several of these legal matters be resolved against the Company in the same reporting period, the consolidated financial position or operating results could be materially adversely affected. Regardless of the outcome, any litigation may require the Company to incur significant expenses and may result in significant diversion of management’s attention. Further, during its ordinary course of business, the Company enters into obligations to defend, indemnify and/or hold harmless various customers, officers, directors, employees, and other third parties. These contractual obligations could give rise to additional litigation costs and involvement in court proceedings.

Geveran Investments Limited v. Lighting Science Group Corporation, et al. (the “Geveran Case”)

On June 22, 2012, Geveran Investments Limited (“Geveran”), one of the Company’s stockholders, filed a lawsuit against the Company and several other defendants in the Circuit Court of the Seventeenth Judicial Circuit in and for Broward County, Florida. On October 30, 2012, the court entered an order transferring the lawsuit to the Ninth Judicial Circuit in and for Orange County, Florida. The Geveran Case names the Company as a defendant, as well as Pegasus Capital and nine other entities affiliated with Pegasus Capital; Richard Weinberg, our former Director and former interim Chief Executive Officer and a former partner of Pegasus Capital; Gregory Kaiser, a former Chief Financial Officer; J.P. Morgan Securities, LLC (“J.P. Morgan”); and two employees of J.P. Morgan. Geveran seeks rescission of its $25.0 million investment in the Company, as well as recovery of interest, attorneys’ fees and court costs, jointly and severally against the Company, Pegasus Capital, Mr. Weinberg, Mr. Kaiser, J.P. Morgan and the two J.P. Morgan employees, for alleged violations of Florida securities laws. Geveran alternatively seeks unspecified money damages, as well as recovery of court costs, for alleged common law negligent misrepresentation against these same defendants. In August 2014, the court granted Geveran’s motion to amend their first amended complaint to assert a claim for punitive damages against the defendants.

On August 28, 2014, the court issued an Order Granting Plaintiff’s Motion for Partial Summary Judgment under its First Cause of Action for Violation of the Florida Securities and Investor Protection Act (the “August 28 Order”). It is anticipated that the August 28 Order will be entered as a judgment of Court in August or September 2015. Once the August 28 Order is entered, the Company intends to appeal it. Together with the other defendants, the Company will have 30 days to post a bond during which time enforcement of the judgment would be stayed. The Company plans to have a bond posted to secure the judgment, which should result in the automatic stay of enforcement through the appeal process.

While the outcome of any appeal is inherently difficult to predict, the Company believes that the trial court’s grant of summary judgment to plaintiff was in error. In the event that the summary judgment is overturned on appeal, the Company believes it has strong defenses against Geveran’s claims. The Company denies liability in connection with this matter and intends to continue to vigorously defend itself against the claims asserted by Geveran. Nonetheless, the amount of possible loss, if any, cannot be reasonably estimated at this time. The outcome, if unfavorable, would have a material adverse effect on the Company’s financial position. The Company believes that, subject to the terms and conditions of the relevant policies (including retention and policy limits), directors’ and officers’ insurance coverage will be available to cover the substantial majority of its legal fees and costs in this matter. However, given the unspecified nature of Geveran’s maximum damage claims, insurance coverage may not be available for, or such coverage may not be sufficient to fully pay, a judgment or settlement in favor of Geveran. Based upon the terms of an indemnification agreement described below, the Company has also paid, and is likely to pay in the in the future, reasonable legal expenses incurred by J.P. Morgan and its affiliates in this lawsuit in connection with the engagement of J.P. Morgan as placement agent for the private placement with Geveran. Such payments are not covered by the Company’s insurance policies. The engagement letter executed with J.P. Morgan provides that the Company will indemnify J.P. Morgan and its affiliates from liabilities relating to J.P. Morgan’s activities as placement agent, unless such activities are finally judicially determined to have resulted from J.P. Morgan’s bad faith, gross negligence or willful misconduct.

GE Lighting Solutions v. Lighting Science Group Corporation, et al.

The Company is also a defendant in an action brought by GE Lighting Solutions LLC (“GE Lighting”) in Federal District Court for the Northern District of Ohio in or about January 2013. GE Lighting asserts a claim of infringement by the Company, as well as five other LED manufacturers, of U.S Patent No. 6,787,999, entitled LED-Based Modular Lamp, and U.S. Patent No. 6,799,864, entitled High Power LED Power Pack for Spot Module Illumination, and seeks monetary damages and an injunction. The Company denies liability in connection with this matter, asserts non-infringement defenses, and also asserts that the patents include terms that are indefinite and thus are invalid. On August 5, 2015, the Federal District Court granted the Company’s summary judgment motion invalidating the two GE patents at issue for indefiniteness, and dismissing GE’s patent infringement claims against the Company and the other defendants.  GE will have 30 days from the date the judgment is entered in which to file a notice of appeal.  If such an appeal were filed, the appellate court could reverse the judgment and remand the case back to the Federal District Court for further proceedings.

Other

In addition, the Company may be a party to a variety of legal actions, such as employment and employment discrimination-related suits, employee benefit claims, breach of contract actions, tort claims, shareholder suits, including securities fraud, intellectual property related litigation, and a variety of legal actions relating to its business operations. In some cases, substantial punitive damages may be sought. The Company currently has insurance coverage for certain of these potential liabilities. Other potential liabilities may not be covered by insurance, insurers may dispute coverage or the amount of insurance may not be sufficient to cover the damages awarded. In addition, certain types of damages, such as punitive damages, may not be covered by insurance and insurance coverage for all or certain forms of liability may become unavailable or prohibitively expensive in the future.

XML

Note 8 - Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2015

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

	Fair Value Measurement as of June 30, 2015
	Quoted Price in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
	Level 1		Level 2		Level 3
Assets (Recurring):
Pegasus Commitment	$	-	$	-	$	264,000
Liabilities (Recurring):
Riverwood Warrants	$	-	$	-	$	3,357,970
September 2012 Warrants		-		-		264,000
Pegasus Warrant		-		-		1,856,000
THD Warrant		-		-		207,617
Medley Warrants		-		-		1,489,186
Pegasus Guaranty Warrants		-		-		1,587,641
	$	-	$	-	$	8,762,414

Fair Value, Assets Measured on Recurring Basis [Table Text Block]

				Realized and unrealized			Purchases, sales,		Transfers in
	Balance			gains (losses) included			issuances and		or out of		Balance
	December 31, 2014			in net loss			settlements		Level 3		June 30, 2015
Pegasus Commitment	$	720,000		$	(456,000	)	$	-	$	-	$	264,000
Riverwood Warrants		(2,352,027	)		(1,005,943	)		-		-		(3,357,970	)
September 2012 Warrants		(720,000	)		456,000			-		-		(264,000	)
Pegasus Warrant		(1,300,000	)		(556,000	)		-		-		(1,856,000	)
THD Warrant		(43,928	)		(163,689	)		-		-		(207,617	)
Medley Warrants		(577,065	)		(912,121	)		-		-		(1,489,186	)
Pegasus Guaranty Warrants		(643,924	)		(943,717	)		-		-		(1,587,641	)
Total	$	(4,916,944	)	$	(3,581,470	)	$	-	$	-	$	(8,498,414	)

				Realized and unrealized			Purchases, sales,			Transfers in
	Balance			gains (losses) included			issuances and			or out of			Balance
	December 31, 2013			in net loss			settlements			Level 3			June 30, 2014
Pegasus Commitment	$	1,407,335		$	592,665		$	-		$	-		$	2,000,000
Riverwood Warrants		(5,002,664	)		(1,691,565	)		-			-			(6,694,229	)
September 2012 Warrants		(1,407,335	)		(592,665	)		-			-			(2,000,000	)
Pegasus Warrant		(2,765,047	)		(934,953	)		-			-			(3,700,000	)
THD Warrant		-			-			-			(74,576	)		(74,576	)
Series J Warrants		-			(25,140,561	)		(12,505,739	)		37,646,300			-
Medley Warrants		-			139,858			(3,170,361	)		-			(3,030,503	)
Pegasus Guaranty Warrants		-			130,833			(3,336,574	)		-			(3,205,741	)
Total	$	(7,767,711	)	$	(27,496,388	)	$	(19,012,674	)	$	37,571,724		$	(16,705,049	)

XML

Note 12 - Restructuring Expense (Details) - Accrued Liability Associated with Restructuring Charges - USD ($)		3 Months Ended		6 Months Ended
		Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Note 12 - Restructuring Expense (Details) - Accrued Liability Associated with Restructuring Charges [Line Items]
Accrued liability		$ 869,887		$ 869,887
Charges		214,066	$ 793	297,770	$ 205,845
Payments				(879,232)
Facility Closing [Member]
Note 12 - Restructuring Expense (Details) - Accrued Liability Associated with Restructuring Charges [Line Items]
Accrued liability		455,998		455,998
Charges	[1]			297,770	$ 91,568
Payments				(801,012)
Excess Facilities [Member]
Note 12 - Restructuring Expense (Details) - Accrued Liability Associated with Restructuring Charges [Line Items]
Accrued liability		276,062		276,062
Payments				(77,207)
Other Exit Costs [Member]
Note 12 - Restructuring Expense (Details) - Accrued Liability Associated with Restructuring Charges [Line Items]
Accrued liability		$ 137,827		137,827
Payments				$ (1,013)

[1] These charges relate to a significant cost reduction plan initiated during the fourth quarter of 2013 that includes moving the majority of the Company's manufacturing to its contract manufacturers in Asia, related workforce reductions in Satellite Beach, Florida and cost reductions in our foreign subsidiaries. The Company estimates it will incur $200,000 in additional expenses throughout this cost reduction plan, primarily related to additional headcount reductions. These additional costs are expected to be incurred during 2015.

XML

Note 9 - Stockholders' Equity (Details)		3 Months Ended		6 Months Ended
	Jun. 12, 2014	Jun. 30, 2015 USD ($)	Jun. 30, 2014 USD ($)	Jun. 30, 2015 USD ($)	Jun. 30, 2014 USD ($)
Note 9 - Stockholders' Equity (Details) [Line Items]
Allocated Share-based Compensation Expense				$ 129,465	$ 199,368
Restricted Stock [Member] | Director [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Allocated Share-based Compensation Expense		$ 118,000	$ 126,000
Restricted Stock [Member] | Directors [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Allocated Share-based Compensation Expense				129,000	$ 199,000
Restricted Stock [Member] | Scientific Advisory Board [Member]
Note 9 - Stockholders' Equity (Details) [Line Items]
Allocated Share-based Compensation Expense		$ 30,000		$ 63,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Recipients	5

XML

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parentheticals) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Related party expenses	$ 0	$ 261,000	$ 0	$ 869,000

XML

Note 3 - Liquidity and Capital Resources

6 Months Ended

Jun. 30, 2015

Liquidity And Capital Resources [Abstract]

Liquidity And Capital Resources [Text Block]

NOTE 3. LIQUIDITY AND CAPITAL RESOURCES

As shown in the condensed consolidated financial statements, the Company has experienced significant net losses as well as negative cash flows from operations since its inception, resulting in an accumulated deficit of $816.4 million and stockholders’ deficit of $512.3 million as of June 30, 2015. As of June 30, 2015, the Company had cash and cash equivalents of $347,000 and an additional $3.0 million in restricted cash subject to a cash collateral dominion agreement pursuant to the Medley Term Loan. The Company’s cash expenditures primarily relate to procurement of inventory, payment of salaries, employee benefits and other operating costs.

The Company’s primary sources of liquidity have historically been borrowings from First Capital under the FCC ABL, from Medley under the Medley Term Loan and from other previous lenders, as well as sales of Common Stock and Preferred Stock (as defined below) to, and short-term loans from, affiliates of Pegasus Capital Advisors, L.P. (“Pegasus Capital”), including Pegasus Partners IV, L.P. (“Pegasus IV”), LSGC Holdings LLC (“LSGC Holdings”), LSGC Holdings II LLC (“Holdings II”), LSGC Holdings III LLC (“Holdings III”) and PCA LSG Holdings, LLC (“PCA Holdings” and collectively with Pegasus Capital, Pegasus IV, LSGC Holdings, Holdings II, Holdings III and their affiliates, “Pegasus”). Pegasus is the Company’s controlling stockholder.

The Company obtained the five-year, $30.5 million Medley Term Loan from Medley on February 19, 2014, pursuant to a Term Loan Agreement (as amended from time to time the “Medley Loan Agreement”). Pursuant to the Medley Loan Agreement, the Company is required to achieve a minimum quarterly fixed charge coverage ratio for the preceding 12-month period and to maintain certain minimum EBITDA levels. In connection with the Medley Term Loan, the Company issued a warrant to purchase 5,000,000 shares of Common Stock to each of Medley and Medley Opportunity Fund II LP (the “Medley Warrants”).

The Company also obtained a three-year revolving credit facility with a maximum line amount of $22.5 million from ACF Finco I LP (as assignee of First Capital) on April 25, 2014, pursuant to the terms of a Loan and Security Agreement (as amended from time to time, the “FCC ABL Agreement”). As of June 30, 2015, the Company had $11.2 million in borrowings outstanding under the FCC ABL Agreement and additional borrowing capacity of $2.0 million. The maximum borrowing capacity under the FCC ABL Agreement is based on a formula of eligible accounts receivable and inventory. The FCC ABL Agreement also requires the Company to achieve a minimum quarterly fixed charge coverage ratio for the preceding 12-month period.

On January 30, 2015, the Company issued 11,525 units of its Series J securities (“Series J Securities”), at a purchase price of $1,000 per Series J Security for aggregate proceeds of $11.5 million. Each Series J Security consists of (i) one share of Series J Preferred Stock and (ii) a warrant to purchase 2,650 shares of Common Stock, at an exercise price of $0.001 per share (the “Series J Warrants”). The Series J Securities were issued pursuant to a subscription agreement entered into between the Company and Holdings III.

Commencing on September 25, 2015, RW LSG Holdings LLC (“Riverwood”) and Pegasus will have the right to cause the Company to redeem their shares of Series H Convertible Preferred Stock (“Series H Preferred Stock”) and Series I Convertible Preferred Stock (“Series I Preferred Stock”), respectively. If either Riverwood or Pegasus elects to cause the Company to redeem its shares of Series H Preferred Stock or Series I Preferred Stock, all other holders of the applicable series will similarly have the right to request the redemption of their shares of Preferred Stock. In addition, commencing 10 business days after September 25, 2015, Portman Limited (“Portman”) and affiliates of Zouk Holdings Limited acting together, have a contractual right to require the Company to redeem their respective shares of Series H Preferred Stock. The Company is also required to redeem the outstanding shares of its Series J Convertible Preferred Stock (“Series J Preferred Stock” and collectively with Series H Preferred Stock and Series I Preferred Stock, the “Preferred Stock”) (a) subject to certain limited exceptions, immediately prior to the redemption of the Series H Preferred Stock, Series I Preferred Stock or any other security that ranks junior to the Series J Preferred Stock and (b) on November 14, 2019, at the election of the holders of Series J Preferred Stock (a “Special Redemption”). Holders of Preferred Stock would also have the right to require the Company to redeem such shares upon the uncured material breach of the Company’s obligations under its outstanding indebtedness or the uncured material breach of the terms of the certificates of designation governing the Preferred Stock. As of June 30, 2015, in the event the Company was required to redeem all of its outstanding shares of Preferred Stock, the Company’s maximum payment obligation would have been $492.0 million. The Company would be required to repay its outstanding obligations under the Medley Term Loan and the FCC ABL prior to any redemption of shares of Preferred Stock. As of June 30, 2015, the aggregate borrowings outstanding under these loan facilities was $39.7 million.

Any redemption of the Preferred Stock would be limited to funds legally available therefor under Delaware law. The certificates of designation governing the Preferred Stock provide that if there is not a sufficient amount of cash or surplus available to pay for a redemption of Preferred Stock, then the redemption must be paid out of the remaining assets of the Company. In addition, the certificates of designation governing Preferred Stock provide that the Company is not permitted or required to redeem any shares of Preferred Stock for so long as such redemption would result in an event of default under the Company’s credit facilities.

As of June 30, 2015, based solely on a review of the Company’s balance sheet, the Company did not have legally available funds under Delaware law to satisfy a redemption of its Preferred Stock. In addition, based solely on the Company’s projected balance sheet as of September 25, 2015, the Company does not believe that it will have legally available funds on or before September 25, 2015 to satisfy any such redemption.

The certificate of designation governing the Series H Preferred Stock also provides that upon the occurrence of a “control event,” the Company must take any and all actions required and permitted to fix the size of its board of directors to a size that would permit Riverwood (as the primary investor of the Series H Preferred Stock) to appoint a majority of the directors to the board until the Company satisfies or otherwise cures the obligations giving rise to the control event. A control event occurs if, among other things, Riverwood exercises its optional redemption right under the certificate of designation governing the Series H Preferred Stock and the Company is unable to redeem Riverwood’s Preferred Stock. If Riverwood were to exercise its optional redemption right and a control event were to occur, Riverwood could take control of the board of directors. In addition, if the Company does not have sufficient capital available to redeem the Series J Preferred Stock in connection with a Special Redemption of the Series J Preferred Stock, the Company will be required to issue a non-interest bearing note or notes (payable 180 days after issuance) in the principal amount of the liquidation amount of any shares of Series J Preferred Stock not redeemed by the Company in connection with such Special Redemption, subject to certain limitations imposed by Delaware law governing distributions to stockholders.

As discussed further in Note 14, one of the Company’s stockholders, Geveran Investments Limited (“Geveran”), filed a lawsuit against the Company and certain other defendants seeking, among other things, rescission of its $25.0 million investment in the Company. On August 28, 2014, the court presiding over the lawsuit granted Geveran’s motion for partial summary judgment with respect to its cause of action for violation of the Florida securities laws. As of June 30, 2015, the order relating to the judgment had not been entered. Although the Company cannot predict the ultimate outcome of this lawsuit, it believes the court’s summary judgment award in favor of Geveran is in error and that it has strong defenses against Geveran’s claims. In the event that the Company is not successful on appeal, it could be liable for Geveran’s $25.0 million investment, as well as interest, attorneys’ fees and court costs. After the order is entered, the Company plans to appeal and, together with the other defendants, post a bond, which would allow the Company to obtain an automatic stay of enforcement throughout the appeal process. The summary judgment order and the bond required to stay enforcement of the judgment could have an adverse effect on the Company’s liquidity and its ability to raise capital in the future.

The Company continues to face challenges in its efforts to achieve positive cash flows from operations and profitability. The Company’s ability to continue to meet its obligations in the ordinary course of business is dependent upon establishing profitable operations, which may be supplemented by any additional funds raised through public or private financing or increased borrowing capacity.

The Company’s supply agreement with The Home Depot, the term of which continues until July 23, 2016, does not require The Home Depot to purchase any minimum amount of products from the Company. Moreover, The Home Depot performs periodic product line reviews to assess its product offerings, which can lead to pricing pressures and/or a reallocation of its business to other suppliers. In June 2015, The Home Depot performed its most recent product line review which covered its entire private label LED lighting product offering. Although the Company has not been advised of the results of this product line review, such review could result in a material loss of revenue from sales to The Home Depot.

As a result of the Company’s historical and continuing losses, the Company believes it will likely need to raise additional capital to fund its operations. There can be no assurance that sources of additional capital will be available in an amount or on terms that are acceptable to the Company, if at all. If the Company is not able to raise such additional capital, the Company may need to restructure or refinance its existing obligations, which restructuring or refinancing would require the consent and cooperation of the Company’s creditors and certain stockholders. In such event, there can be no assurance that such restructuring or refinancing could be accomplished on terms that are acceptable to the Company, if at all.

XML

Note 9 - Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2015

Stockholders' Equity Note [Abstract]

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

Warrant Holder	Reason for Issuance	Number of Common Shares		Exercise Price		Expiration Date
Investors in rights offering	Series D Warrants		1,072,617	$	2.95 to $2.96	March 3, 2022 through April 19, 2022
The Home Depot	Purchasing agreement		7,609,183	$	1.05	December 31, 2015 through 2018
RW LSG Management Holdings LLC	Riverwood Warrants		12,664,760	Variable		May 25, 2022
Certain other investors	Riverwood Warrants		5,427,751	Variable		May 25, 2022
Cleantech Europe II (A) LP	September 2012 Warrants		3,406,041	$	0.72	September 25, 2022
Cleantech Europe II (B) LP	September 2012 Warrants		593,959	$	0.72	September 25, 2022
Portman Limited	September 2012 Warrants		4,000,000	$	0.72	September 25, 2022
Aquillian Investments LLC	Private Placement Series H		830,508	$	1.18	September 25, 2017
Pegasus	Pegasus Warrant		10,000,000	Variable		May 25, 2022
Investors in Series J Follow-On Offering	Series J Warrants		185,500,000	$	0.001	January 3, 2019 through January 30, 2020
Medley	Medley Warrants		10,000,000	$	0.95	February 19, 2024
Pegasus	Pegasus Guaranty Warrants		10,000,000	$	0.50	February 19, 2024
			251,104,819

XML

Label	Element	Value
Product Warranty Accrual	us-gaap_ProductWarrantyAccrual	$ 4,789,470
Restructuring Reserve	us-gaap_RestructuringReserve	1,451,349
Facility Closing [Member]
Restructuring Reserve	us-gaap_RestructuringReserve	959,240
Excess Facilities [Member]
Restructuring Reserve	us-gaap_RestructuringReserve	353,269
Other Exit Costs [Member]
Restructuring Reserve	us-gaap_RestructuringReserve	$ 138,840

XML

Note 7 - Lines of Credit and Note Payable (Details) - Lines of Credit and Note Payable - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Note 7 - Lines of Credit and Note Payable (Details) - Lines of Credit and Note Payable [Line Items]
FCC ABL, revolving line of credit	$ 11,175,467	$ 6,368,793
Medley Term Loan	28,516,029	27,813,061
	39,691,496	34,181,854
First Capital [Member]
Note 7 - Lines of Credit and Note Payable (Details) - Lines of Credit and Note Payable [Line Items]
FCC ABL, revolving line of credit	11,175,467	6,368,793
Medley Term Loan [Member]
Note 7 - Lines of Credit and Note Payable (Details) - Lines of Credit and Note Payable [Line Items]
Medley Term Loan	$ 28,516,029	$ 27,813,061

XML

Note 13 - Concentrations of Credit Risk

6 Months Ended

Jun. 30, 2015

Risks and Uncertainties [Abstract]

Concentration Risk Disclosure [Text Block]

NOTE 13. CONCENTRATIONS OF CREDIT RISK 

For the three months ended June 30, 2015 and 2014, revenue derived from sales to The Home Depot represented 93% and 72%, respectively, of the Company’s total revenue. For the six months ended June 30, 2015 and 2014, revenue derived from sales to The Home Depot represented 87% and 75%, respectively, of total revenue.

As of June 30, 2015 and December 31, 2014, The Home Depot accounts receivable balance represented 79% and 66%, respectively, of the Company’s total accounts receivable, net of allowances.